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ABSTRACT OF DISSERTATION 
 
Nanomaterials for Double-Stranded RNA Delivery 
 
RNA interference has enormous potential as a potent, specific, and environmentally 
friendly alternative to small molecule pesticides for crop protection.  The use of exogenous 
double-stranded RNA offers flexibility in targeting and use in crops in which transgenic 
manipulation is not an option.  The combination of RNAi with nanotechnology offers 
further advantages that are not available with dsRNA alone.  In this work, I have evaluated 
several different combinations of nanomaterials and polymers for use in RNAi-based pest 
control systems.  First, I have characterized the use of chitosan/dsRNA polyplex 
nanoparticles for gene knockdown using the model nematode Caenorhabditis elegans.  
Though chitosan/dsRNA polyplexes are equally as effective as naked dsRNA for gene 
knockdown on a concentration basis, these materials are assimilated into cells in a manner 
independent of dsRNA specific transport proteins.  The mechanism of uptake is likely 
clathrin-mediated endocytosis.  In addition, I identify a significant and yet unreported side-
effect associated with chitosan exposure, the dysregulation of a major myosin isoform.  
Next, I have determined the efficacy of chitosan/dsRNA polyplex nanoparticles under 
different environmental conditions.  The presence of inorganic ions (phosphate and nitrate) 
at realistic environmental concentrations does not alter the efficacy of the nanoparticles 
for gene knockdown, nor do they inhibit knockdown by naked dsRNA.  These conditions 
did not cause any significant changes to the hydrodynamic diameter or zeta potential of 
the particles themselves between treatments.  By contrast, a pH higher than six and the 
presence of natural organic matter significantly reduce the efficacy of the nanomaterials at 
gene knockdown but leave knockdown by naked dsRNA unaffected.  Though some 
changes in polyplex size are observed in the pH treatments, these changes are 
comparatively small, and particles remain well within the size that can be ingested by C. 
elegans.  At pH 8, the charge of the particles is effectively neutral.  Similarly, 
concentrations of natural organic matter >2.5 mg/L cause a charge reversal of the particles, 
from strongly cationic to strongly anionic.  Large aggregates are also visible in each of 
these treatments.  Lastly, I characterize the efficacy of a suite of different polymer and 
solid core nanomaterials for dsRNA delivery, similar to the above.  Poly-L-lysine, poly-
L-arginine, Ge-doped imogolite, and poly-L-arginine-citrate coated Au nanoparticles all 
fail to cause any appreciable knockdown in the same C. elegans reporter system.  Uptake 
of the polymers was exceedingly poor, and though the Au particles appear to have been 
ingested, there is no evidence of significant gene knockdown.  Furthermore, poly-L-
arginine caused significant injury to the mouthparts of C. elegans exposed to these 
materials.  Layered double-hydroxide nanoparticles were successful at gene knockdown, 
and appear to function slightly better than naked dsRNA alone, and were translocated in 
C. elegans in a similar fashion to naked dsRNA.  Taken together, these findings aid in the 
development of safe and effective RNAi biological control agents. 
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CHAPTER 1. GENERAL INTRODUCTION 
1.1 RNA Interference 
1.1.1 History of RNAi 
RNA interference (RNAi) is an endogenous cellular mechanism found in 
eukaryotes that uses double-stranded RNA (dsRNA) as a template for the silencing of 
genes in a sequence specific manner.  Though first observed in plants1, and later described 
in fungi2, RNAi was fully defined in the landmark work of Fire and Mello3 using the 
nematode Caenorhabditis elegans.  A mere eight years later, Fire and Mello received the 
2006 Nobel Prize in Physiology or Medicine, a vivid illustration of the importance of this 
discovery.  Further research has articulated the specific mechanisms and nuances of the 
system.  Notably, the biological purpose of RNAi has been a topic of extensive work. 
RNAi can be triggered by both endogenous and exogenous signals.  As an endogenous 
system, RNAi plays a principally regulatory4 role.  The triggering molecules are known as 
microRNA (miRNA) and have a continuous hairpin structure5, 6.  As an exogenously 
triggered system, RNAi plays a defensive7, 8 role, serving to protect organisms from both 
viral infections and transposable elements.  This can be triggered by either long dsRNA9 
or short interfering RNA (siRNA)10, 11, both of which are blunt-ended sense/antisense 
duplexes.  Though work into the fundamental mechanisms of RNAi has vastly expanded 
the understanding of gene regulation and the multifaceted role of RNA in the eukaryotic 
cell, RNAi has also become both an essential laboratory tool and a platform for 
biotechnological innovation.  In the laboratory, RNAi is an invaluable means for reverse 
genetics studies12 and has provided innumerable insights into the biology of countless 
species.  In practical application, therapeutic ends for RNAi have been pursued for some 
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time13, with varying degrees of success.  In 2018, the first RNAi-based commercial drug, 
patisiran, was introduced and approved by the FDA14, 15.  For cancer treatment, RNAi has 
been used for both target identification16, 17, 18 and a therapy modality unto itself19, 20, 21.  
Antiviral applications of RNAi are, naturally, in development as well22, 23, 24.  Though 
comparatively new, RNAi already has a rich history.  A Web of Science search for the term 
“RNAi” yields over 1,800 research articles for 2018 alone. Thus, much of the story of 
RNAi remains to be told.  Applications of RNAi in other areas are in development as well, 
particularly in agriculture, which is the principal focus of this work.  As such, the context 
for RNAi in this work is almost universally that of a biological control agent (see Section 
1.2).  The basic cellular mechanisms of RNAi are universal for all biotechnological 
applications, and a firm understanding of these mechanisms is requisite for any further 
discussion of RNAi applications.  Since this work exclusively uses C. elegans as a model 
system, the specifics of C. elegans RNAi will be discussed, though in almost all cases 
homologs of the listed genes are present in all eukaryotes, and exceptions noted where 
relevant to the greater context of RNAi based biological control. 
1.1.2 dsRNA Transport 
In order for RNAi to be effectively used as a biological control agent, a target 
organism must internalize dsRNA in some fashion.  In almost all cases, this will ultimately 
be via ingestion.  Therefore, a thorough understanding of dsRNA internalization from the 
gut to the cellular level is necessary.  In C. elegans, this is accomplished by a series of 
transport proteins.  Following the ingestion of dsRNA, sid-2 transports dsRNA into the gut 
epithelial cells25.  This initial import is crucial for successful environmental RNAi.  In sid-
2 null mutant C. elegans, ingested dsRNA does not pass the gut, and no gene silencing 
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occurs, but dsRNA injected directly into cells triggers a robust, systemic RNAi response.  
Another transporter, sid-126 is required for cellular uptake of dsRNA in any context 
(injection or ingestion) and is by far the most studied of the C. elegans dsRNA transport 
proteins.  sid-1 possesses a transmembrane domain27 and an extracellular dsRNA binding 
domain28.  In contrast to sid-2, sid-1 null mutants are incapable of systemic RNAi, 
regardless of the route of dsRNA administration, either injection or ingestion.  Other 
proteins are known to contribute to the process of dsRNA internalization (sid-329; sid-530) 
but are substantially less studied than the preceding proteins.  In the course of dsRNA 
processing in RNAi, secondary siRNA transcripts are generated (discussed below).  Export 
of these secondary transcripts is dependent on several genes (rsd-2; the clathrin-associated 
rsd-331; rsd-6), and does not require sid-132 or sid-225.  Once internalized to the cytoplasm, 
dsRNA is processed and incorporated into the catalytic core of the RNAi machinery. 
1.1.3 Post-Transcriptional Gene Silencing and the RNA Induced Silencing Complex 
Two enzyme complexes are essential for the functioning of RNAi within the cell.  
First, dsRNA must be processed into suitable templates.  Following introduction of dsRNA 
into the cytosol, long dsRNA is bound and cleaved by the Dicer complex (composed of the 
dsRNA binding rde-4, the Argonaute rde-133; the RNase III dcr-134; the helicase drh-335; 
ain-136; and the RNA polymerase rrf-137) into 21-22 nucleotide (nt) fragments, forming 
small interfering RNAs (siRNAs).  Bound single strands of siRNA serve as the means by 
which complementary mRNA are selected for cleavage.  This activity is performed by the 
RNA-induced silencing complex (RISC) (composed of the nuclease tsn-138; the RNA 
binding vig-139; ain-136; and an Argonaute such as rde-1).  A single strand of a siRNA 
duplex is incorporated into the RISC, and serves as the guiding template for selecting 
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mRNA for cleavage.  The selection of which strand in a siRNA duplex is incorporated into 
the RISC is determined by the stability at the 5’ ends of the strands40.  Once mRNA is 
identified and bound, the RNase domain within the RISC cleaves the mRNA.  Cleaved 
mRNAs are unable to be translated, ultimately leading to a reduction in the gene product, 
i.e. silencing.  During this process, rrf-1, an RNA dependent RNA polymerase (RdRp), 
generates secondary transcripts of the siRNAs, amplifying the triggering signal for RNAi.  
Interestingly, there appears to be competition between RdRp that function for endogenous 
RNAi and exogenous RNAi.  The deletion of the endogenous-associated RdRp rrf-3 leads 
to an exogenous RNAi hypersensitivity phenotype41.  In addition to this, there is evidence 
that different homologs of various RISC and Dicer related genes act on the endogenous 
and exogenous pathways differently42, 43. 
1.2 RNAi as a Biological Control Agent 
Globally, insect pests already consume between 5-20% of all produced grains.  
With rising global temperatures, this is expected to increase by 10-25% per degree Celsius 
increase in temperature44.  At the same time, societal awareness of the dangers and long 
term impacts of pesticide use have increased rapidly since the onset of the environmental 
movement, initiated with the publication of the timeless “Silent Spring”45.  RNAi is 
uniquely suited to fill a role as a biological control agent that satisfies both of these 
concerns.  Development of conventional, small molecule insecticides has generally 
followed a path of reduced toxicity and environmental impact as time has gone on.  For 
instance, among the earliest industrial-scale insecticides were formulations of lead arsenate 
for use in orchards.  Though these materials were used only in the early 1900’s and use 
discontinued decades ago, sites on which lead arsenate were used remain contaminated to 
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present day46.  Organophosphorus and organochlorine insecticides were developed as 
alternatives, but suffer from extreme acute toxicity47 and environmental persistence48, 
respectively.  Newer insecticides such as pyrethroids and neonicotinoids offer further 
reductions in mammalian toxicity and environmental persistence, but concerns about 
effects in beneficial non-target insects have hampered widespread adoption of their use49.  
In contrast, RNAi based biological control agents can be designed to be highly specific.  
The sequence specificity of RNAi is such that only very closely related species50 would be 
affected by a well-designed51 dsRNA construct.  In addition, RNA is, by its very nature, 
rapidly degraded in the environment52, 53, 54.  These traits give RNAi-based biological 
control agents the potential to be the safest, most environmentally friendly insecticides ever 
produced. 
1.2.1 General Considerations for RNAi-based Biological Control 
For RNAi to be effectively used as a biological control agent, dsRNA must be 
delivered, intact, to the target organism in some fashion.  For crop protection, there are 
essentially two ways to achieve this: by incorporation of a transgene that transcribes a 
dsRNA construct into a crop species, or in-vitro synthesis of dsRNA and application to 
surfaces.  The most commonly used method thus far has been via the transfection of 
agronomically relevant species with a dsRNA-transcribing construct.  The structure of the 
transgenic construct takes the form of a short hairpin RNA (shRNA), with the sense and 
antisense RNA sequences separated by a spacer55.  This was first accomplished in 
Arabidopsis thaliana, with constructs targeting endogenous genes56.  Shortly thereafter, 
RNAi was used to confer protection from crown gall bacterium in both A. thaliana and 
tomatoes57, the first practical demonstration of RNAi as a crop protection agent.  The 
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sequence of the construct itself can radically alter gene silencing efficacy, and design 
characteristics for effective RNAi are well documented58. The ability to selectively silence 
genes gives rise to ample opportunities for crop improvement.  In most applications, a 
detrimental external organism, such as a pathogen or insect pest, is the target for control 
efforts.  Control of this type is limited only in that the pathogen or pest must possess core 
RNAi components (i.e., must be eukaryotes).  An absence of core RNAi components will 
not be overcome, no matter the technological innovations developed.  Likewise, one should 
not implicitly consider the lack of dsRNA transport mechanisms an insurmountable 
obstacle, as will be articulated in Chapter 2.  With this in mind, it is important to note that 
there are some rather specific and extreme caveats that must be considered, and will be 
discussed in the following sections. 
1.2.2 RNAi-based Control of Invertebrate Pests 
For control of insect pests, applications of RNAi are exceedingly broad.  In 2007, 
two reports emerged indicating that RNAi could be used as an effective insecticide.  First, 
Mao et. al. demonstrated that the incorporation of an RNAi transcript targeting a gossypol 
detoxification enzyme could successfully protect cotton plants from the cotton bollworm59.  
Later, Baum et. al. were successfully able to target a variety of coleopteran pests in maize60.  
Since these first reports emerged, RNAi has been explored as a viable option for control of 
numerous insect pests in agriculture.  Major crop pests such as the Colorado potato beetle61, 
aphids62, and western corn rootwoom63 can be targeted using RNAi.  Aside from crop pests, 
orchard and forest insect pests such as emerald ash borer64, 65, Southern pine beetle66, and 
light brown apple moth67 have proven amenable to control via RNAi.  In spite of these 
efforts, severe shortcomings of insecticidal RNAi have emerged.  Perhaps the most glaring 
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of these is the absence of an environmental RNAi response in many insect species, most 
notably in order Lepidoptera68.  There are multiple proposed explanations for this lack of 
activity.  One such theory is the rapid degradation of dsRNAs in the insect hemolymph69.  
More specifically, lepidopterans do not appear to accumulate processed siRNAs70, 
implying either failure to reach DICER successfully, rapid degradation, or both.  Some 
evidence of gut-specific nucleases has been reported71, and knockdown of these genes does 
appear to improve RNAi response72.  Another possible issue is the lack of dsRNA specific 
transporters in certain species.  This has been demonstrated in several instances by 
incorporating the sid-1 gene from C. elegans into other organisms, such as silkworms 
(Bombyx mori)73 or Drosophila27.  In both cases, sid-1 transgenic cells are capable of 
dsRNA uptake from media, whereas wildtype cells are not.  Though this is compelling, it 
is worth noting that in both cases, cell cultures were used, and the complete physiology of 
the organism could alter the efficacy of dsRNA uptake in ways that are not present in the 
highly artificial environment of a cell culture dish filled with medium.  In a somewhat 
confusing twist, sid-1 orthologs are not implicitly required for dsRNA uptake and systemic 
RNAi response in some insects74.  Further confounding these results is the presence of 
genes specific to only certain orders of insects that are implicitly required for RNAi75.  
Recent developments point to endosomal entrapment as a significant driver of the lack of 
environmental RNAi efficacy.  Studies that tracked the cellular localization of dsRNA in 
lepidopteran cells with a pH-responsive dye indicated the accumulation of dsRNAs in 
acidic cellular compartments76, likely late endosomes or lysosomes77.  Overall, the key 
needs that must be met to successfully implement insecticidal RNAi can be summarized as 
improvements to uptake, protection from nucleases, and efficient escape from endosomes. 
 8 
 
1.2.3 RNAi-based Control of Non-Insect Pests 
In addition to the aforementioned insect pests, other organisms pose significant 
threats to agricultural production, and in many of these cases, RNAi is indeed a viable 
option for control of these organisms.  Fungal pathogens responsible for both crop loss by 
yield reduction78 and contamination79 have been successfully controlled via RNAi.  
Nematodes were another early target80, and RNAi constructs have been successfully used 
to control a number of highly destructive nematode species, including the soybean cyst 
nematode81, potato cyst nematode82, and a variety of root-knot nematodes83.  Note that in 
each of these cases, plants have been modified to resist predation or parasitization by 
organisms from kingdoms other than Plantae.  In a fascinating turn, transgenic plants have 
been produced which resist parasitic plants84.  In more exotic applications, RNAi has been 
utilized to protect pollinators from pathogens such as viruses85.  Truly, there are nearly 
limitless opportunities for plant protection offered by RNAi. 
1.2.4 RNAi control of disease vectors 
Though this work principally explores the use of RNAi for agricultural purposes, 
there is enough overlap between the technologies I am investigating and those used in 
control of vector-borne human disease to justify the discussion of their intersection.  This 
is particularly relevant given the strong likelihood that climate change will exacerbate the 
impact of vector-borne disease, possibly to catastrophic levels86. 
Foremost among vector-borne diseases is malaria, induced by Plasmodium sp. and 
transmitted by the mosquito genus Anopheles.  Though RNAi is non-functional in 
Plasmodium87, a number of studies have demonstrated that RNAi is functional in 
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Anopheles, but operates inefficiently88, likely due to the absence of either RNA-dependent 
RNA polymerases or transporters associated with systemic spread89.  Similar investigations 
have been conducted in the Yellow fever mosquito, Aedes aegypti, with similar findings, 
in that RNAi is functional, but inefficient90.  Nevertheless, RNAi-based control methods 
for Aedes have been developed91.  Further, nanoparticle mediated delivery of dsRNA has 
proven to be far more effective than dsRNA alone in gene silencing in both Aedes and 
Anopheles92, 93.  Other mosquito-borne diseases have shown amenability to treatment with 
RNAi, such as Japanese encephalitis94 and Dengue fever95. 
 Ticks (order Parsitifomes) also frequently act as vectors for human diseases.  
Though delivery of RNAi based biological control agents to ticks directly will be 
impossible due to the nature of their diet and habitats, they are amenable to RNAi96, and 
possible targets for tick control have been identified using RNAi97. 
1.3 Nanomaterials and dsRNA Delivery 
1.3.1 Common Paradigms at the Intersection of Nanotechnology and RNAi 
Though there is some debate as to what, specifically, constitutes a nanomaterial, 
the commonly accepted definition is any material in which a discrete unit possesses at least 
one dimension that is less than 100 nm98.  More generous definitions allow for a single 
dimension less than 1000 nm99.  Others have proposed far more rigorous definitions, based 
on surface area100.  Regardless of the semantics, matter at this scale tends to display what 
is known as ‘emergent properties’, physical and chemical properties that are distinct from 
their bulk counterparts.  These properties themselves are often highly dependent on the 
shape, size, and surface features of the nanomaterial, and can include changed reactivity101, 
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optical properties102, and biological interactions103.  Of particular interest to this work is 
the ability of nanomaterials to bind dsRNA, enter cells, and release dsRNA in the 
cytoplasm.  Early work in nucleic acid delivery recognized that condensation into a 
compact, nanoscale structure radically increases transfection efficiency104.  The 
technologies developed for DNA delivery as transfection agents share many of the 
characteristics needed for RNA delivery105, 106.  First, dsRNA must either be bound to the 
nanocarrier or contained within an artificial vesicle, depending on the modality employed.  
This can be achieved by electrostatic interactions107 or covalent linkage108.  Next, upon 
cellular entry, dsRNA must be accessible to the RISC complex.  Ultimately, this means 
that dsRNA must be in the cytosol, and the path from the extracellular space to the cytosol 
is not always a linear or simple one.  As discussed previously, a major barrier to successful 
RNAi response is the degradation of dsRNAs in lysosomes or release by exocytosis, rather 
than intact release into the cytosol109.  Strategies for evading these molecular sinks include 
designing nanomaterials for direct cellular entry110 (by either cationic surface coatings111 
or high aspect ratio penetration112), or for lysosomal escape113, 114.  Final considerations 
somewhat more specific to agricultural nanotechnology are those of cost115 and toxicity116.  
For any nanomaterial to be successful in the agricultural sector, it must offer a return on 
investment to the producer.  To this end, simplicity and abundance must be emphasized 
when considering RNAi enabled nanomaterials.  Exotic modifications and complex 
chemistries have been explored for therapeutic gene delivery systems, but these are 
unlikely to see application in agriculture due to the high costs associated with their 
production.  Thus, the discussion below will focus on reasonably simple nanomaterials 
designed for gene delivery.  In addition to these concerns, the toxicity of the nanocarrier 
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must be at best minimal to non-human target organisms, and absent in humans.  The entire 
purpose of RNAi-based biological control agents is to reduce dependence upon toxic 
pesticides and the use of adjuvants which cause toxic effects in target and non-target 
organisms wholly defeats the purpose of their development. 
1.3.2 Organic Polycations 
Complexation with a polycation is a very common method for improving the uptake 
characteristics of dsRNA.  The phosphate backbone of dsRNA has a negative charge at all 
ambient and physiological pH values.  Under the proper conditions, a combination of 
dsRNA and a polycation results in the formation of compact, nanoscale polymer 
complexes, or polyplexes through electrostatic self-assembly.  Even simple cationic 
molecules can improve the efficiency of dsRNA, for example, the common soaking 
protocol for inducing RNAi in C. elegans utilizes spermidine at a component of the soaking 
buffer117.  Numerous other synthetic, semi-synthetic, and natural polymers have been 
shown to improve dsRNA delivery.  Polyethylenimine (alone118 or in conjunction with 
other molecules119/nanoparticles120) has been heavily studied and utilized for its ability to 
greatly enhance transfection efficiency.  However, there is a key flaw associated with the 
use of many polycations: intrinsic toxicity121, 122.   Since most agricultural products will 
ultimately be consumed by humans or livestock, low or non-existent toxicity must be a key 
characteristic of any polycation for agricultural use. 
Chitosan (poly β-1,4-D-glucosamine) is an extensively studied polycation which 
has a number of properties that make it highly desirable for biological applications.  
Chitosan is derived from chitin (poly β-1,4-N-acetylglucosamine) by boiling from 
crustacean shells in an excess of sodium hydroxide, and thus starting materials are 
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inexpensive and abundant123.  Further, chitosan is generally regarded as non-toxic to 
eukaryotes, especially compared to synthetic polycations124, and is available commercially 
in numerous molecular weights and degrees of deacetylation125.  Chemical modifications 
such as trimethylation and PEGylation can be made to improve characteristics such as 
solubility and drug delivery capacity126, 127.  In addition to these properties, chitosan also 
shows great potential in other agriculturally relevant areas, for instance, as an 
environmental remediation agent128, a fertilizer amendment129, a water-use efficiency 
promoter130, and an erosion control agent131. 
Homopolymers of cationic amino acids, such as polyarginine132 and polylysine133, 
have been successfully employed as dsRNA delivery vehicles, and have been reported in 
some cases to exceed the transfection efficiencies of even commercially available agents.  
Comparisons between different varieties of polycationic polypeptides has generally shown 
that polyarginine outperforms others in terms of cellular entry132.  Polylysine has been 
assessed to have low toxicity134, and can be comparatively easily used to functionalize 
various materials, due to its unhindered primary amine135.  The low pKa of histidine (~6) 
allows for the development of pH sensitive delivery methods using polyhistidine136.  
Noncanonical amino acid polymers are also usable as transfection agents, such as 
polyornithine137.  The vast array of properties available from polypeptide carries make this 
class of material a particularly compelling one for dsRNA delivery. 
1.3.3 Inorganic Nanomaterials 
As with polymers, to be effective at dsRNA delivery, an inorganic particle intended 
for use as such must interact with and bind dsRNA in some fashion.  Numerous modalities 
are available to achieve this.  For instance, gold nanoparticles functionalized with 
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oligonucleotides exhibit extremely high affinity for complementary nucleic acids138.  
Another option is the functionalization of the surface of the particle with polymers that 
bind nucleic acids.  Iron oxide nanoparticles have been investigated for this purpose139.  In 
this system, the authors coated iron oxide particles with a copolymer of PEI, PEG, and 
chitosan.  The advantage of this system is that one can exploit the properties of each 
component, i.e. the nucleic acid binding properties of PEI and chitosan, the toxicity 
amelioration of PEG, and the magnetic properties of iron oxide. In other systems, the core 
material can be used to reduce the toxicity of a nucleic acid binding polymer, for instance 
in a PEI-graphene system140.  In each of the aforementioned systems, the core particle 
required functionalization with some other polymer or functional group to bind nucleic 
acids.  A highly promising class of nanomaterial that does not require such modifications 
are layered double hydroxides (LDH).  LDHs are essentially cationic clays, and have a 
general chemical formula of [MII1-x MIIIx (OH)2]x+ [An-]x/n •yH2O, where MII is a divalent 
cation, MIII is a trivalent cation, and An- is a counteranion141, and a layered crystal structure.  
The substitution of MII by MIII in the lattice structure gives rise to a positive surface charge, 
which allows the binding of anionic nucleic acids142.  LDH/dsRNA composites have 
already been demonstrated to provide protection against plant viruses143, and have shown 
enormous potential in other therapeutic areas144. 
1.4 Nanomaterials and RNAi in the Environment 
Upon introduction into the environment, nanomaterials of any variety interact with 
their surroundings and are subsequently transformed, degraded, or otherwise altered.  
There is at least one study that has specifically investigated the stability of dsRNA 
conjugated with cationic polymers in soils, which found substantial increases in dsRNA 
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persistence145.  Little other work exists on the environmental transformations of RNAi-
enabled nanomaterials, but numerous studies exist on the transformations and interactions 
that take place with their constituent components. 
1.4.1 Environmental Transformations of Nanomaterials 
In general, interactions between nanoparticles and other objects and surfaces in 
aqueous environmental conditions can be described using the principles of colloid science, 
specifically DLVO theory146, 147.  In short, the total interaction energy between a particle 
and another surface in aqueous solution is the sum of a number of forces, originating from 
the physiochemical properties of each surface as well as local environmental conditions 
(pH, ionic strength).  Thus, particle surface properties and environmental conditions are 
key to understanding how particles interact with other surfaces.  Though inadequate to fully 
describe the complexity found in a highly heterogeneous system, such as those found in 
natural environments, DLVO allows for general predictions about particle-surface 
interactions.  These interactions are critically important for understanding the concept of 
heteroaggregation148, the likely ultimate fate of most nanomaterials introduced into a 
natural system.  Numerous studies have provided vivid examples of these principles.  Most 
nanomaterials introduced into soils or natural waters will heteroaggregate with natural 
colloids149, most often natural organic matter150, 151.  As an example of the interplay of this 
phenomenon, a study investigating the role of natural organic matter, ionic strength of 
solution, and pH on the stability and mobility of metal oxide nanomaterials found that 
organic matter and ionic strength were far more influential factors in the electrophoretic 
mobility and stability of the particles than pH151.  In most cases, the presence of natural 
organic matter can also ameliorate the toxicity of pristine nanomaterials152.  Additionally, 
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particularly in instances where the existing surface charge of the nanomaterial is anionic, 
natural organic matter can serve as a stabilizing agent, even in high ionic strength 
environments153.  Further, the influence of biota on the transformations of nanomaterials 
cannot be understated.  For instance, gold nanoparticles are normally quite stable and inert 
in water, but are rapidly transformed by biota when introduced into a wetland mesocosm154.  
In addition, gold nanoparticles can assimilated by plants, and subsequently accumulated in 
insects155.  Similar phenomenon have been observed for iron oxide nanoparticles156.  
Cationic polymers are somewhat more difficult to study in the context of environmental 
conditions, but inferences can in some cases be drawn from other studies utilizing these 
materials for different purposes.  For instance, a study of the use of chitosan as a flocculent 
for removal of natural organic matter can be used to make inferences about behaviors of 
chitosan nanoparticles and organic matter in other contexts157.  Another example would be 
a study investigating the adsorption of organic matters onto different surfaces158.  In this 
particular case, the authors found that humic acids rapidly formed a monolayer on poly-l-
lysine coated surfaces, which allows one to infer that similar processes are likely with poly-
l-lysine nanoparticles or polyplexes.  In general, when assessing the transformations and 
interactions of nanomaterials in environmental conditions, one must consider the chemistry 
of both the nanomaterial, and also the environment into which the nanomaterial is 
introduced. 
1.4.2 Environmental Transformations of dsRNAs 
Though more stable than single-stranded RNAs (ssRNA), dsRNAs are still highly 
vulnerable to environmental degradation.  Very few studies have directly investigated the 
degradation of dsRNA in environmental soils.  The earliest of these, by Dubelman et. al., 
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found that dsRNAs introduced into agricultural soils were undetectable after 48 hours, 
regardless of the properties of the soil itself52.  The same study predicted dsRNA half-lives 
of less than 30 hours in the slowest degradation scenario and as little as 15 hours in the 
fastest degradation scenario.  A follow-up study by the same group investigated the 
degradation of dsRNA in an aquatic scenario53, finding that dsRNA was undetectable in a 
sediment/water system after 7 days.  The half-life of the dsRNA was estimated to be less 
than 3 days.  In the most recent study directly investigating dsRNA in the environment, 
Parker et. al. used radiolabeled dsRNA to both increase the sensitivity of assays (by more 
than two orders of magnitude compared to the aforementioned assays), and to trace the 
locale of degradation products54.  In this study, dsRNAs were characterized to be rapidly 
sorbed to soil particles, and subsequently degraded over time.  Most interestingly, it was 
found that soil microorganisms were capable of uptake and utilization the 32P-labeled 
products for their own biochemical processes.  Though understudied, the general 
conclusions from nearly all the studies investigating environmental dsRNA have a clear 
agreement: dsRNAs are subject to predictable interactions with the constituents of the 
natural environment and are degraded fairly rapidly. 
1.5 Research Objectives and Outline 
The overall aim of this work is to explore the interactions between biota, the 
environment, and dsRNA nanocarriers.  These interactions will underpin the effectiveness 
of gene-silencing nanomaterials in agricultural applications, specifically biological control 
agents.  As has been made clear in the previous sections, there is enormous potential in 
RNAi-based biological control agents, and by combining nanotechnology with RNAi, 
many of the technical difficulties to successful implementation of RNAi biological control 
 17 
 
agents may be overcome.  However, there are significant knowledge gaps in how these 
materials will behave in many scenarios, particularly in non-ideal and realistic settings.  
Though we may be able to reasonably predict the behavior of these materials, experimental 
evidence is lacking.  This work seeks to close some of those knowledge gaps and articulate 
the nature of the interactions between gene silencing nanomaterials and the environment. 
This will allow the development of safer and more effective RNAi biological control 
agents. 
1.5.1 Hypotheses 
 1.) dsRNA/nanomaterial conjugates will be assimilated in C. elegans in ways that 
are distinct from naked dsRNA. 
 2.) The physical environment of dsRNA/nanomaterial conjugates prior to ingestion 
by C. elegans will alter the effectiveness of these materials at gene silencing. 
 3.) Different substrates for dsRNA delivery will have different efficacies at gene 
silencing in C. elegans, and the efficacy will be dependent on the physical properties of the 
substrate. 
1.5.2 Dissertation Outline 
 Chapter 2 of this dissertation covers work into the uptake and bioactivity of 
chitosan/dsRNA polyplex nanoparticles in C. elegans.  I will characterize specific 
mechanisms by which chitosan/dsRNA polyplexes are taken into cells, and, in addition, I 
discuss off-target effects associated chitosan/dsRNA polyplex exposure. 
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 Chapter 3 explores the efficacy of chitosan/dsRNA polyplex nanoparticles at gene 
silencing in C. elegans in different exposure media.  In these media, I have varied pH, 
anion concentration, and natural organic matter content, to emulate conditions likely to be 
encountered in an agricultural setting. 
 In Chapter 4, I explore the efficacy of a suite of other nanocarriers and polycations 
for dsRNA delivery, with a variety of chemical and physical properties.  In addition, I 
explore possible mechanisms that can account for the success or failure of each of these in 
the exposure conditions used.   
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2.1 Abstract 
In this study, we have investigated chitosan/dsRNA polyplex nanoparticles as 
RNAi agents in the nematode Caenorhabditis elegans.  By measurement of an easily 
observed phenotype and uptake of fluorescently labeled dsRNA, we demonstrate that 
chitosan/dsRNA polyplex nanoparticles are considerably more effective at gene 
knockdown on a whole body concentration basis than naked dsRNA.  Further, we show 
that chitosan/dsRNA polyplex nanoparticles introduce dsRNA into cells via a different 
mechanism than the canonical sid-1 and sid-2 pathway.  Clathrin-mediated endocytosis is 
likely the main uptake mechanism.  Finally, although largely reported as non-toxic, we 
have found that chitosan, as either polyplex nanoparticles or alone, is capable of 
downregulating expression of myosin.  Myosin is a critical component of growth and 
development in eukaryotes, and we have observed reductions in both growth rate and 
reproduction in chitosan exposed C. elegans.  Given the increased potency, non-canonical 
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uptake, and off-target effects we have identified, these findings highlight the need for 
rigorous safety assessment of nano-RNAi products prior to deployment. Specifically, 
potential adverse effects of the nanocarrier and components thereof need to be 
considered. 
2.2 Introduction 
RNA interference (RNAi) is a system by which double-stranded RNA (dsRNA) is 
used by cellular machinery as a template for the degradation of a corresponding 
messenger RNA (mRNA) 3.  Although the potential of RNAi as a pest control agent was 
recognized in its early days, it has taken nearly twenty years for RNAi-enabled products 
to reach the market159.  As a pesticide, an mRNA encoding an essential gene is targeted, 
leading to mortality in the pest species.  Due to the high level of sequence homology 
required for efficacy, RNAi is generally understood to be considerably less toxic and 
more specific compared to traditional small molecule pesticides.  In fact, the specificity 
of RNAi pest control is such that a well-designed targeting sequence is likely only to 
affect very close relatives of the pest species160, leaving non-target species unharmed.  
Several delivery methods for RNAi sequences exist, the most common of which is stable 
integration of a dsRNA coding sequence into the genome of a crop species161.  In this 
system, dsRNA is transcribed by the host plant, then ingested by the pest species during 
feeding.  Though effective, this method is not without limitations, as many relevant crop 
species are not amenable to genetic transformation, and the extreme specificity of RNAi 
limits control to a single pest for each incorporated sequence.  As such, products utilizing 
in-vitro synthesized dsRNA applied as a surface treatment are in development.     
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Naked dsRNA, though more stable than single-stranded RNA, is still vulnerable 
to rapid degradation by nucleases in the environment52.  dsRNA is also poorly assimilated 
in many highly destructive pest species162.  It is well established that complexation of 
dsRNA with nanoscale carriers such as polycations163, liposomes164, or solid particles165 
greatly improves RNAi response and environmental stability.  dsRNA nanocomposites 
are far less susceptible to nuclease degradation compared to naked dsRNAs166, with 
chitosan derivatives receiving particular attention in this regard167.  Chitosan (poly β-1,4-
D-glucosamine) possesses numerous characteristics which make it an excellent substrate 
for dsRNA delivery.  The chemical and physical properties of chitosan are fairly simple 
to manipulate, with numerous different degrees of deacetylation and molecular weights 
being commercially available125.  Further, being comparatively non-toxic124 and produced 
from abundant seafood waste123 differentiate chitosan from synthetic polycations.  When 
combined at low (<6) pH, the protonated amine groups of chitosan are electrostatically 
attracted to the anionic phosphate backbone of nucleic acids to form polyplex 
nanoparticles (PNs) 168, 169.  Previous studies have demonstrated the efficacy of 
chitosan/dsRNA PNs for induction of an RNAi response in insects, including species in 
which RNAi is normally ineffective92, 170, but little work has focused on the specific 
mechanism by which chitosan/dsRNA PNs improve RNAi response. 
In many species, an ingested dsRNA can trigger an RNAi response systemically 
to tissues and cells far removed from the initial site of dsRNA entry, via a series of RNA 
polymerases and transporters171.  Termed environmental RNAi (eRNAi), this process was 
first observed in the nematode Caenorhabditis elegans172, where ingested dsRNA is 
internalized into cells by a series of proteins collectively known as the sid (systemic RNA 
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interference defective) genes173.  Sid-126 is a multipass transmembrane protein, with an 
extracellular domain capable of specifically binding dsRNA174.  It is essential for the 
efficient import of dsRNA into cells, but is not required for the export of RNAi signals32.  
Sid-2 localizes to the nematode midgut, and participates in the internalization of 
environmental dsRNA25, possibly in concert with sid-1173.  Notably, C. elegans with 
mutations to sid-2 are still capable of systemic RNAi, provided that dsRNA is directly 
injected into a founder cell outside the midgut, whereas sid-1 mutants are completely 
incapable of systemic RNAi, no matter the site of introduction.  Homologs of sid-1 have 
been reported in a diverse range of organisms175, 176, but many of these are non-functional 
or absent177 in relevant pest species.  Surprisingly, systemic RNAi can still be observed in 
many sid-1 analog deficient species.  In these cases, receptor mediated endocytosis plays 
a key role in the uptake of dsRNA from the environment178, and systemic spread is 
facilitated by extracellular vesicles179. 
Though the environmental concerns associated with nanomaterials have received 
much attention over the past decade, little work has been conducted on biologically active 
nanomaterials that are intended to be deliberately introduced at field scales.  In addition 
to this knowledge gap, studies investigating the potential for off-target and non-target 
effects associated with pesticidal RNAi tend to focus on the nucleic acid component, with 
little attention paid to the potential of any co-delivered agents to alter these effects.  In 
this work, we investigate the potential for off-target effects of chitosan/dsRNA PNs in C. 
elegans.  We demonstrate that in C. elegans, gene knockdown using chitosan/dsRNA 
PNs is as effective as naked dsRNA when using a soaking assay as an analogue for 
environmental exposure.  Tracking the uptake of naked dsRNA and chitosan/dsRNA PNs 
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shows that although naked dsRNA and chitosan/dsRNA PNs are equally effective on a 
concentration basis, far less dsRNA as chitosan/dsRNA PNs are ingested. This indicates 
that chitosan/dsRNA PNs are considerably more effective on a tissue concentration basis.  
We then show that chitosan/dsRNA PNs are effective at inducing RNAi in C. elegans 
mutants lacking specific dsRNA uptake machinery, and demonstrate that clathrin-
mediated endocytosis is a key driver of chitosan/dsRNA PNs uptake.  Lastly, we have 
identified that chitosan and chitosan/dsRNA PNs greatly alter the expression of myo-3, a 
myosin isoform that contributes to development and musculature in C. elegans. 
2.3 Materials and Methods 
2.3.1 Strains 
Caenorhabditis elegans strains (N2; CGC4 [umnTi1 III.]; HC196 [sid-1(qt9) V]; 
HC271 [ccIs4251 I; qtIs3 sid-2(qt42) III; mIs11 IV]; PD4251 [ccIs4251 I; dpy-
20(e1282) IV]) were maintained on K-medium agar plates seeded with OP50 Escherichia 
coli at 20°C, according to established methods180. 
2.3.2 dsRNA and Polyplex Nanoparticle Synthesis 
Genomic DNA was isolated from C. elegans using phenol-chloroform extraction and 
ethanol precipitation, according to established methods181.  Templates for in-vitro 
transcription were generated by PCR using T7 promoter appended primers181, and 
purified using the Qiagen PCR Cleanup Kit (28104, Germantown, MD).  A complete list 
of primers used in this study is included in supplemental materials.  dsRNA was 
synthesized using the Thermo Scientific TranscriptAid T7 High Yield Transcription Kit 
(K0441, Waltham, MA) according to manufacturer’s instructions, and purified using 
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phenol-chloroform and ethanol precipitation181.  Typical yield from each reaction was 
~150 μg of RNA, as confirmed by measurement of absorbance at 260 nm, using a Varian 
Cary 50 Bio UV-Vis Spectrophotometer equipped with a Hëllma TrayCell.  
Chitosan/dsRNA PNs were synthesized using a modification of Zhang’s method92.  A 
0.58% w/v solution of low molecular weight chitosan (Polysciences 21161, Warrington, 
PA) was prepared in 0.2 M acetate buffer at pH 4.5.  dsRNA was diluted to 1 μg/μL in 50 
mM Na2SO4.  For each preparation, equal volumes chitosan solution and dsRNA solution 
were combined in a 1.5 mL microcentrifuge tube.  The mixture was placed in a water 
bath at 55°C for 1 minute, followed by vigorous vortexing for 30 seconds to generate 
PNs.  PN solution was then used for exposures without further purification.  We have 
previously reported detailed characterization of these PNs93; average diameter was found 
to be 15.6 ± 3.5 nm, with a zeta potential of 29 ± 4 mV. 
2.3.3 Fluorescent Labeling of dsRNA and Chitosan 
GFP dsRNA was labeled with cy3 using the Ambion Silencer siRNA Labeling 
Kit (AM1632, Foster City, CA) according to the manufacturer’s instructions. 
Fluorescein-5-Isothiocyanate (Thermo Fisher Scientific F143, Waltham, MA) was 
dissolved in methanol at 1 mg/mL.  A 1% solution of low molecular weight chitosan in 
0.2 M acetate buffer was prepared as above.   Equal volumes of FITC/Methanol and 
chitosan solution were combined and vigorously stirred for 3 hours in the dark at room 
temperature.  Following completion of the reaction, chitosan was precipitated by the 
dropwise addition of 0.2 M NaOH to a final pH of 7.  The resulting solution was 
centrifuged at 12,000 x g, and the supernatant was discarded.  Labeled chitosan was 
subsequently washed five times with 18 M Ω sterile distilled H2O and centrifugation, to 
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remove residual FTIC.  The resulting chitosan was air dried overnight in a desiccator, and 
gently pulverized with a mortar and pestle.  The labeled chitosan powder was then 
dissolved in 0.2 M acetate buffer to a final concentration of 0.58% w/v and used as above 
for the synthesis of chitosan/dsRNA PNs.   
2.3.4 Caenorhabditis elegans dsRNA and polyplex nanoparticle exposures 
In a soaking RNAi assay, C. elegans are suspended in liquid medium with a given 
concentration of dsRNA, and then scored based upon observed phenotype117.  Although 
developed for ease of use in the laboratory, this assay is also roughly analogous to a 
feeding assay, as dsRNA internalized by this method exclusively enters organisms via 
ingestion.  Using a soaking assay, we were able to compare the efficacy of naked dsRNA 
and chitosan/dsRNA PNs at inducing an RNAi response. We targeted a stable transgene, 
green fluorescent protein (GFP).  In this case, the measured phenotype is a reduction in 
the fluorescence intensity of exposed nematodes.  In order to determine if C. elegans 
assimilates naked dsRNA and chitosan/dsRNA PNs by the same mechanism, we used 
sid-1 and sid-2 null mutant strains in soaking assays targeting a stable and non-essential 
gene, pmp-3. 
C. elegans were age synchronized according established protocols180 and 
incubated for 24 hours at 20°C on 10 cm K-agar plates seeded with E. coli strain OP50.  
To maximize the observable phenotype, L1/L2 stage nematodes were used in this 
assay117.  At 24 hours post age synchronization, nematodes will be at late L1/early L2 
stage182.L1 stage nematodes were then gently washed from plates with K-medium (51.3 
mM NaCl, 31.6 mM KCl) into 15 mL polypropylene centrifuge tubes and centrifuged at 
130 x g.  The supernatant was drawn off and replaced with fresh K-medium, followed by 
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centrifugation and removal of supernatant, leaving a gently compacted nematode pellet.  
Exposure solutions were prepared by diluting dsRNA or chitosan/dsRNA PNs in K-
medium.  Exposures were conducted in PCR tubes, with 2 μL compact nematode pellet 
(~50 worms) in 18 μL exposure solution at the final concentration indicated, with 
incubation at 20°C for 24 hours.  This methodology remained consistent among 
experiments, with changes in the concentration of dsRNA and chitosan/dsRNA PNs 
detailed following.  Exposures for imaging were conducted at 100 ng/μL dsRNA as 
naked dsRNA or chitosan/dsRNA PNs.  Exposures for GFP knockdown were conducted 
at 0, 5, 40, 100, and 400 ng/μL dsRNA as naked dsRNA or chitosan/dsRNA PNs.  All 
exposures for qRT-PCR were conducted at 0 or 100 ng/μL dsRNA, as either naked 
dsRNA or chitosan/dsRNA PNs.  Chlorpromazine (Sigma-Aldrich C8138, St. Louis, 
MO) was prepared at 350 μg/mL in K-medium as a stock solution, and used at a final 
concentration of 35 μg/mL in exposures183.   
2.3.5 Fluorescence Imaging 
Strain CGC4 has a stable transgenic array incorporated at a known location in the 
C. elegans genome, ensuring that no protein coding genes are disrupted, and the 
transgene will not suffer from any effects associated with multiple copy insertion184.   
This array is composed of GFP driven by a translation elongation promoter, giving 
recipient organisms ubiquitous, constitutive expression of GFP.  After 24 hours of 
exposure, CGC4 nematodes treated with GFP dsRNA and chitosan/dsRNA PNs were 
imaged for fluorescence.  Exposure solution and nematodes (8 μL) were gently placed on 
a glass microscope slide.  Two microliters of 1M sodium azide (Sigma-Aldrich S2002, 
St. Louis, MO) was added to each drop of solution to anesthetize the nematodes, which 
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were then secured with a coverslip.  Imaging was performed using a Nikon Eclipse 90i 
microscope equipped with Nikon Intensilight C-HGFI Epifluorescence Illuminator, 
Nikon cy3 and GFP filter cubes, and a Nikon DS-Qi1Mc camera (Tokyo, Japan).  
Multichannel images of individual nematodes were taken at 10x magnification, 
consisting of DIC images (autoexposure) and GFP images (5s exposure).  Using the 
image analysis software Fiji185, Regions of interest were drawn around individual 
nematodes using the DIC image, background was subtracted using the ‘rolling ball’ 
method with a radius of 50 pixels, and mean fluorescence from the GFP channel was 
determined as mean pixel intensity.  Length measurements were obtained by drawing and 
measuring a segmented line on individual nematodes, from the tip of the tail, along the 
midline, to the opening of the pharynx.   
To determine the uptake and localization of dsRNA and chitosan/dsRNA PNs 
within exposed C. elegans, we labeled chitosan and dsRNA with separate fluorophores, 
FITC and Cy3 respectively.  Nematodes were then exposed to naked labeled dsRNA, 
chitosan/dsRNA PNs made with labeled chitosan, dual labeled (dsRNA and chitosan) 
PNs, and labeled chitosan without dsRNA.  For dsRNA uptake measurements, the above 
method was utilized, but at 20x magnification and with the cy3 channel serving as the 
source of the mean pixel intensity (1s exposure).  Exposures were conducted as above, 
with treatments of FITC-chitosan alone, FITC-Chitosan/dsRNA PNs, cy3-dsRNA alone, 
and dual labeled FITC-chitosan/cy3-dsRNA dual labeled particles.  Fluorescently labeled 
chitosan/dsRNA PN exposed nematodes were imaged at 20x magnification for cy3 (2s 
exposure), GFP (2s exposure), and DIC (autoexposure) images.  dsRNA uptake was 
measured using the cy3 channel alone from cy3-dsRNA and cy3-dsRNA/chitosan PN 
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exposed nematodes.  As above, the background was subtracted from each image, and a 
region of interest was drawn around each nematode.  Mean pixel intensity was then 
measured in each region of interest. 
Images of dual labeled chitosan/dsRNA PN solution was performed as above, at 
20X magnification with autoexposure for each channel.  Background from each channel 
was subtracted, and colocalization analysis was performed on the whole image using the 
coloc2 Fiji plugin. 
2.3.6 Reproduction Assay 
Wild type N2 C. elegans were age synchronized as previously described180.  Eggs 
were hatched on 10cm OP50 seeded K-agar plates, and allowed to mature for 24 hours.  
L1/L2 stage nematodes were subsequently rinsed from plates with K-medium, followed 
by centrifugation at 130xg.  The supernatant was drawn off and replaced with fresh K-
medium.  This process was repeated 2X to ensure removal of OP50.  Worms were then 
placed in K-medium supplemented with the indicated concentration of chitosan, as 
described previously.  Exposures were conducted for 24 hours in the absence of OP50, 
due to the known bactericidal and bacteriostatic effects of chitosan186, as this would be a 
confounding variable in the assay.  Following exposures, 4-6 worms per treatment group 
were placed on 10 cm OP50 seeded K-agar plates, with three replicates per treatment 
group.  Upon the onset of egg-laying, adults from each replicate were transferred to fresh 
OP50 seeded K-agar plates daily, for three days.  Following removal of adults, plates 
with young worms were stained with 1.5 mL 0.5 g/L Rose Bengal (Acros Organics 
189450250, Morris Plains, NJ) and heated to 55°C for 30 minutes.  Plates were then 
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scored for total number of hatched young worms, using a LeicaS6D dissection 
microscope. 
2.3.7 Quantitative Real Time PCR (qRT-PCR) 
Following exposure to dsRNA and chitosan/dsRNA PNs as above, treated 
nematodes were washed in 5 mL K-medium, and centrifuged at 130 xg.  Supernatant was 
discarded, and remaining nematode pellet was suspended in 850 μL TRIzol (Thermo 
Fisher Scientific 15596026, Waltham, MA).  Solutions were flash frozen in LN2 and 
thawed in a 37°C water bath five times to fully lyse all cells.  After final thaw, 50 μL 
chloroform was added to each lysate.  The aqueous layer was removed, and 2 μL 
glycogen (Thermo Fischer Scientific R0551, Waltham, MA) was added to each sample.  
Ethanol precipitation was then carried out according to established protocol181.  The 
resulting whole RNA was resuspended in sdH2O and quantitated using a Cary 50 Bio 
UV-Vis Spectrophotometer.  cDNA was synthesized using a RevertAid First Strand 
cDNA synthesis kit (Thermo Fischer Scientific K1622, Waltham, MA), according to the 
manufacturer’s instructions.  qRT-PCR was performed using an Applied Biosystems 
StepOnePlus thermocycler, TaqMan Fast Advanced Master Mix (Applied Biosystems 
4444557, Foster City, CA) and TaqMan probes, as listed in supplemental material (Fig. 
S2).  Three biological replicates per treatment group were analyzed, with three technical 
replicates used per biological replicate. Y45F10D.4 was used as the endogenous control 
for all experiments, owing to the stability of this gene under most environmental 
conditions, including nanomaterial exposure.187  The CT values reported were compiled, 
and relative expression was calculated after normalization to the reference gene 
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according to Pfaffl using Relative Expression Software Tools (REST) software188, and 
reported here as the log2 transform of the expression and standard error. 
2.3.8 Statistical Analysis 
Statistical analysis was conducted using PROC GLM in SAS 9.4 for the 
fluorescence and reproduction assays.  In each case, Dunnett’s test was used to correct for 
multiple comparisons.  For the length assay, comparisons were made between treatments 
at the same concentration using a Student’s T-test. 
2.4 Results and Discussion 
2.4.1 Comparison of naked dsRNA and chitosan/dsRNA PN RNAi efficacy in whole 
organisms 
As expected, a reduction in fluorescence occurred as treatment concentration 
increased (Fig. 2.1).   From 40 and 100 ng/μL onward, the difference in fluorescence 
intensity was always significantly different from control for PNs and naked dsRNA, 
respectively.  At concentrations of 40 and 400 ng/μL, there was a significant decrease in 
fluorescence intensity for PNs relative to naked dsRNA at the same concentrations.  
Curiously, at 5 ng/μL, the PN treatment showed a significant increase in fluorescence.  
Overall, these results clearly demonstrate that on an exposure concentration basis, 
chitosan/dsRNA PNs are at least as effective at gene knockdown as naked dsRNA, and 
likely slightly more effective.   
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Figure 2.1 – Mean pixel intensity of CGC4 Caenorhabditis elegans exposed to varying 
concentrations of naked dsRNA and chitosan/dsRNA polyplex nanoparticles (PNs).   
Data presented is mean ± standard deviation.  Asterisks over brackets are comparisons 
between treatments within concentrations; asterisks over bars are comparisons to control.  
(NS = p>0.1; * = p<0.1; ** = p<0.05; *** = p<0.01; n=20) 
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2.4.2 Uptake and localization of naked dsRNA and chitosan/dsRNA PNs 
  
Figure 2.2 – Localization of fluorescently labeled PNs and components within 
Caenorhabditis elegans.   
All exposures were conducted with equivalent concentrations of constituent components.  
Brightfield image shown in panel insets.  A – FITC-Chitosan alone; B – FITC-
Chitosan/dsRNA PNs; C – Cy3/dsRNA; D – FITC-Chitosan/Cy3-dsRNA PNs; E - Mean 
pixel intensity of Caenorhabditis elegans exposed to cy3 tagged dsRNA as either naked 
dsRNA or chitosan/cy3-dsRNA polyplex nanoparticles for 24 hours.  Data presented is 
mean ± standard deviation (*** = p<0.01; n=15). 
Uptake of chitosan alone had similar localization to that of chitosan as PNs (Fig. 
2.2A and 2.2B).  The majority of the ingested materials collects in the pharynx and 
posterior intestine, just above the hindgut.  Given that the pH of the C. elegans gut is 
entirely acidic189, chitosan/dsRNA PNs should remain stable prior to cellular entry.  
Chitosan and chitosan/dsRNA PNs show a strong affinity for the cuticle, with a slight 
accumulation of materials seen on the surface of individual nematodes (Fig. 2.2A, 2.2B, 
2.2D).  However, C. elegans internalized far less dsRNA as chitosan/dsRNA PNs than as 
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naked dsRNA (Fig. 2.2C, 2.2D, 2.2E).  When exposed to naked labeled dsRNA, intense 
fluorescence was seen throughout the intestine, with near equal distribution throughout 
(Fig. 2.2C).  Dual labeled chitosan/dsRNA PNs distributed in a similar fashion to that of 
labeled chitosan alone, with significant co-localization of chitosan and labeled dsRNA 
(Fig. 2.2D, Table S5).  Small amounts of dsRNA coated the intestine as in naked dsRNA 
exposures, but with markedly less intensity. 
  Concurrently, images of dual labeled PN solution were captured for colocalization 
analysis.  Images of labeled dsRNA solution were uniform and homogenous, with no 
particular accumulations of dsRNA outside nematodes.  Images of labeled 
chitosan/dsRNA PNs had a distinctly different appearance, with mixed size particulates 
being dominant.  Dual labeled particle solutions were significantly colocalized (Table 
S5). 
2.4.3 Efficacy of chitosan/dsRNA PNs in RNAi deficient mutants 
When soaked in pmp-3 dsRNA (100 ng/μL), the sid-2 mutant showed no 
significant difference in pmp-3 transcripts compared to control (Fig. 2.3).  However, 
when soaked in an equivalent concentration of dsRNA as chitosan/dsRNA PNs (100 
ng/μL), a drastic reduction in pmp-3 was detected.  Since sid-2 is specific for dsRNA 
uptake in the intestine, the sid-2 null mutant is not responsive to eRNAi, but still 
possesses systemic RNAi when dsRNA is introduced via injection.  Although this result 
indicates that chitosan/dsRNA PNs are capable of entry into gut cells, it is quite possible 
that further uptake and spreading of the RNAi signal was facilitated by other endogenous 
systems, including sid-1.  Thus, we conducted a pmp-3 soaking assay with a sid-1 null 
mutant.  As expected, exposure to naked dsRNA (100 ng/μL) caused no significant 
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change in pmp-3 transcript levels compared to control (Fig. 2.3).  However, significant 
reductions in pmp-3 transcripts were seen when chitosan/dsRNA PNs (100 ng/μL) were 
used (Fig. 2.3).  Evidence of a robust RNAi response when using chitosan/dsRNA PNs in 
both sid mutants strongly indicates that PNs are internalized into cells with intact dsRNA 
payloads, using a mechanism independent of the traditionally understood means of naked 
dsRNA uptake. 
 
Figure 2.3 - Fold-change in pmp-3 expression compared to control for wild-type and sid 
null mutant Caenorhabditis elegans under dsRNA and chitosan/dsRNA polyplex 
nanoparticle treatment.   
Error bars represent standard error as reported by REST.  (NS = p>0.1; * = p<0.1; ** = 
p<0.05; *** = p<0.01; n=3 for WT and sid-2 exposures, n=5 for sid-1 exposures) 
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2.4.4 Role of clathrin-mediated endocytosis in chitosan/dsRNA PN uptake 
Clathrin-mediated endocytosis is a major means by which eukaryotes selectively 
import extracellular materials.  Since we were able to rule out sid mediated import of 
dsRNA delivered by chitosan/dsRNA PNs, clathrin-mediated endocytosis emerged as a 
possible mechanism of uptake.  To test this hypothesis, we conducted soaking assays as 
previous, but with chlorpromazine added to the exposure medium.   
 
Figure 2.4 – Relative expression of pmp-3 during concurrent Caenorhabditis elegans 
exposure to chlorpromazine and dsRNA or chitosan/dsRNA polyplex nanoparticles. 
Chlorpromazine alone does not affect pmp-3 expression.  Neither treatment was 
significantly different than control (p>0.1, n=5).  Error bars represent standard error as 
reported by REST. 
As before, pmp-3 was targeted (100 ng/μL dsRNA) in wild-type strain N2, and 
quantitated by qRT-PCR.  In both treatments, there was no significant change in pmp-3 
expression when compared to control (Fig. 2.4).  The implications of this are twofold.  
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First, as has been reported previously178, 190, because there is no significant knockdown in 
naked dsRNA treated groups, sid mediated uptake must be tied to clathrin-mediated 
endocytosis in some fashion.  Additionally, since knockdown is suppressed in 
chitosan/dsRNA PN treated groups, clathrin-mediated endocytosis likely plays a key role 
in the internalization of chitosan/dsRNA PNs.  These findings are similar to those of 
other studies investigating the uptake of nanoparticles in C. elegans191, though this work 
represents the first to specifically investigate the uptake mechanisms of chitosan/dsRNA 
PNs.   
2.4.5 Myosin dysregulation associated with chitosan exposure 
The body of work assessing the potential for off target effects of RNAi has largely 
focused upon sequence-specific phenomenon.  However, when delivered via a 
nanocarrier, effects associated with the nanocarrier and components thereof must also be 
considered.  Although chitosan is regarded as largely non-toxic124, the potential for sub-
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lethal or other innocuous but relevant effects is present.  
 
Figure 2.5 – Fluorescence of Caenorhabditis elegans strain PD4251 when exposed to 
chitosan/dsRNA polyplex nanoparticles. 
A – Caenorhabditis elegans strain PD4251 possesses bright, constitutive fluorescence in 
body wall muscles.  B – When exposed to GFP dsRNA, a slight reduction in fluorescence 
is visible.  C – A more profound reduction in fluorescence is demonstrated when exposed 
to chitosan/dsRNA polyplex nanoparticles (PNs).  D – Exposure to a scrambled GFP 
sequence (sGFP) dsRNA causes no detectable change in fluorescence. E – Exposure to 
chitosan/dsRNA PNs constructed with sGFP dsRNA causes a reduction in fluorescence 
 38 
 
comparable to PNs with a valid GFP sequence. F – Mean pixel intensity of exposure groups 
indicated in figures 5A-E (n=5). 
C. elegans strain PD4251 possesses several stable GFP transgenes driven by the 
myo-3 promoter (Fig. 2.5A).  When exposed to a sequence of GFP dsRNA (400 ng/μL), a 
reduction in fluorescence was observed (Fig. 2.5B).  Exposure to dsRNA corresponding 
to a random scrambling of the same sequence failed to produce any knockdown (Fig. 
2.5D).  Likewise, exposure to an equivalent mass of dsRNA as chitosan/dsRNA PNs 
resulted in a far greater reduction in fluorescence (Fig. 2.5C).  Unexpectedly, exposure to 
scrambled dsRNA as chitosan/dsRNA PNs also resulted in reductions in fluorescence 
similar to those seen using PNs bearing the valid sequence (Fig. 2.5E).   
After confirming that this effect was not a result of dsRNA contaminating 
solutions or apparatus, we concluded that chitosan must be affecting myosin expression.  
To confirm this hypothesis, we investigated expression of myo-3 under treatment by 
chitosan and chitosan PNs, and measured body length of treated CGC4 C. elegans from 
the previous imaging study.  Since myo-3 is strongly associated with body wall muscle, 
we theorized that downregulation would result in a reduction in overall body length.  
Indeed, PN exposed nematodes showed a significant decrease in length, starting at the 
100 ng/μL exposure (Fig. 2.6A).  Next, we conducted a reproduction assay using chitosan 
exposed C. elegans.  As myosin is heavily involved in basic cellular processes, we 
hypothesized that severe downregulation of a major myosin isoform would result in a 
reduction in the fecundity of exposed nematodes.  As expected, exposure to chitosan 
caused a measurable reduction in the number of offspring produced over the course of a 
three day laying period (Fig. 2.6B).  Even relatively low concentrations induced this 
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response, but increasing concentration did not appear to increase severity.  Notably, our 
control groups produced a brood size noticeably smaller (~65 offspring/individual) than 
the typically encountered brood size (~200-300 offspring/individual).  This can likely be 
attributed to the starvation period the nematodes are subject to during the exposure assay. 
 
Figure 2.6 – Growth and Reproduction of Caenorhabditis elegans exposed to 
chitosan/dsRNA polyplex nanoparticles. 
A - Mean body length of Caenorhabditis elegans exposed to the indicated concentration 
of GFP dsRNA, or chitosan/dsRNA polyplex nanoparticles (n=20).  B - Total offspring 
produced per individual Caenorhabditis elegans over the course of a three day laying 
period, following 24 hours of exposure to the indicated concentration of chitosan (n=3).  
Data presented are mean ± standard deviation. (NS = p>0.1; * = p<0.1; ** = p<0.05; *** 
= p<0.01) 
 For gene expression studies, we conducted exposures of N2 strain C. elegans to 
GFP dsRNA (400 ng/μL), chitosan/dsRNA PNs (400 ng/μL dsRNA), and a chitosan 
sample prepared in the same fashion as PNs, but with DI water rather than dsRNA 
solution.  For this last exposure, an equivalent amount of chitosan solution was used as in 
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the PN exposure, to ensure an equivalent concentration of chitosan in each assay.  
Following 24 hours of exposure, myo-3 transcripts were quantitated by qRT-PCR.  myo-3 
levels were slightly downregulated in the presence of dsRNA alone (Fig. 2.7).  However, 
both the chitosan/dsRNA PNs and chitosan groups showed marked downregulation of 
myo-3.  
 
Figure 2.7 – Relative expression of myo-3 under treatment with GFP dsRNA, chitosan 
alone, and chitosan/GFP dsRNA polyplex nanoparticles.   
All treatments were significantly different than control.  Error bars represent standard error 
as reported by REST. (NS = p>0.1; * = p<0.1; ** = p<0.05; *** = p<0.01; n=3)   
 41 
 
2.4.6 Conclusions 
The ability to selectively knock down genes has been a boon to the research 
community, but the applications of RNAi extend far beyond reverse genetics and 
functional genomics.  Products utilizing RNAi for pest control are dependent on dsRNA 
ingestion being sufficient to trigger an RNAi response in the target organism.  Oral 
delivery being key, many products currently in development utilize transgenic RNAi 
constructs incorporated into the genome of crop species.  This method is effective, but 
limited in that specific products must be developed for each pest and each crop.  GM 
crops are also not able to be used in some countries. 
The identification of alternative means of dsRNA uptake has significant toxicological 
implication for target and non-target species alike.  Clathrin-mediated endocytosis is a 
highly conserved mechanism in eukaryotes, indicating that internalization of dsRNA in a 
wide variety of species is possible when a nano-carrier is utilized.  This is of concern 
when exposure to vertebrates is a possibility, as long dsRNA is known to activate innate 
immune responses192.  Most toxicological assessments of RNAi have focused upon 
sequence homology as the key driver of biological effects, be they target or off-target 
effects.  However, differences in uptake of dsRNA, internalization into cells, and 
endosomal escape are important as well.  If nano-carriers increase uptake of dsRNA they 
may increase effects in both target and off-target species, as RNAi is known to be dose-
dependent193.   It is also important to consider the potential toxicity of the nanomaterial 
itself and the components of the nanomaterial, in this case chitosan.  While chitosan is 
typically viewed as being benign, it had significant biological activity in this study.  myo-
3 is crucial for muscle development, locomotion194 and reproduction in C. elegans195, and 
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is required for numerous functions in other eukaryotes as well196.  Further studies into the 
effects of chitosan on myosin are warranted, especially considering the considerable 
amount of work that has been put into the development of chitosan as a possible human 
therapeutic and for delivery of dsRNA as an insecticide.  With these concerns in mind, 
chitosan/dsRNA based nanomaterials do possess great potential for a number of 
applications.  Further improvements to this delivery system could yield materials which 
reduce the total mass of dsRNA required for crop pest control, a highly desired outcome 
given the extreme expense associated with in-vitro synthesis of dsRNA. 
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Table 1. – Oligo sequences for in-vitro synthesis of dsRNA.  T7 primer sequence is 
labeled in parenthesis. 
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Table 2. – List of Taqman primers and probes for qRT-PCR analysis.  GFP 
primer/probe set was provided by Integrated DNA Technologies (Coralville, IA).  
Dye for the probe was a 5’ FAM, and quenchers were an internal ZEN and 3’ 
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Iowa Black FQ.  Efficiency of the primer/probe set was determined to be 
100.953%.  All other Taqman assays were commercially available and provided 
by Thermo Fisher Scientific, with the assay ID listed in the probe column, and 
assumed efficiencies of 100%, per the manufacturer. 
 
  Expression Std. Error 95% CI P 
dsRNA 0.685 0.165 - 6.295 0.014 - 17.022 0.568 
PNs 1.535 0.096 - 25.783 0.018 - 66.146 0.612 
Table 3. - N2 C. elegans were exposed to GFP dsRNA and PNs (100 ng/μL) as 
described in Methods and pmp-3 expression was quantitated as described in 
Methods, using REST for statistical analysis. 
 
 Expression Std. Error 95% CI P 
dsRNA 0.421 0.124 - 0.907 0.108 - 2.944 0.028 
PNs 0.48 0.157 - 1.529 0.100 - 2.801 0.041 
Table 4. - CGC4 C. elegans were exposed to GFP dsRNA and PNs (100 ng/μL) as 
described in Methods and GFP expression was quantitated as described in 
Methods, using REST for statistical analysis. 
 
 
Pearson's 
r197 
Mander's 
M1197 Mander's M2 Li's ICQ198 
Coates's 
P199 
Dual Labeled 
PN 0.635±0.07 0.989±0.004 0.9896±0.009 0.293±0.04 1 
N2 C. 
elegans 0.779±0.14 0.9977±0.001 0.988±0.008 0.3841±0.04 1 
Table 5. – Colocalization of cy3 labeled dsRNA and FITC labeled chitosan was 
confirmed using the coloc2 function included with Fiji, which provides multiple 
statistical methods for image analysis.  Reported values are mean ± standard 
deviation (n=10). 
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CHAPTER 3. EFFICACY OF CHITOSAN/DOUBLE-STRANDED RNA POLYPLEX 
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Stuart S. Lichtenberg1, Kanthi Nuti2, Jason DeRouchey2, Olga V. Tsyusko1, and Jason M. 
Unrine1 
1Department of Plant and Soil Sciences and 2Department of Chemistry, University of 
Kentucky 
 
3.1 Abstract 
 We have investigated the ability of chitosan/double-stranded RNA polyplex 
nanoparticles to silence genes in Caenorhabditis elegans in different environmentally 
analogous media.  Using fluorescence microscopy, we were able to rapidly assess gene 
knockdown and dsRNA uptake under numerous conditions.  Scanning transmission 
electron micrographs of polyplexes confirms heterogeneous distribution of chitosan and 
RNA in single particles and a wide range of particle morphologies.  High pH and the 
presence of natural organic matter inhibited the ability of polyplex nanoparticles to 
silence genes, but were unaffected by the presence of inorganic nitrate and phosphate.  
Environmental media did not affect particle size in any specific pattern, as determined by 
dynamic light scattering and fluorescence correlation spectroscopy.  The efficacy of 
polyplexes seems to be closely tied to zeta potential, as all treatments that resulted in a 
net negative zeta potential (high pH and high natural organic matter) failed to achieve 
gene knockdown.  These results support earlier work that emphasized the importance of 
charge in gene carriers and will aid in the development of effective gene silencing 
biological control agents. 
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3.2 Environmental Significance 
 When deployed in the field, the structure of RNAi enabled materials will be 
altered by the environment, and their effectiveness could be compromised under certain 
conditions.  Here, we have explored some of the dominant environmental variables that 
will affect these materials in an agricultural setting.  We have strived to use experimental 
conditions that mimic realistic exposure scenarios, by using whole organisms and settings 
that are reasonable approximations of those found in the field.  This information will be 
used to develop materials that retain activity in a broad range of environments and will 
further the development of safe and effective RNAi technologies.  
3.3 Introduction 
 RNA interference (RNAi) is an endogenous cellular process that utilizes double-
stranded RNA (dsRNA) as a template for the degradation of a homologous messenger 
RNA (mRNA)3.  Though believed to have evolved as a mechanism for viral defense200 
and gene regulation201, RNAi has found immense utility as a functional genomics tool12, 
and has recently emerged as a promising means of crop protection61.  When used as a 
pest control agent, an insect pest consumes dsRNA that targets an essential gene, 
resulting in mortality.  A key advantage of RNAi compared to small molecule pesticides 
is specificity.  For RNAi to function, the ingested dsRNA must be nearly identical to the 
target mRNA, restricting a properly designed dsRNA to activity in only a handful of 
closely related species202.  While developed initially for control of insect pest of crops, 
RNAi can be used to address invasive forest insects65, human disease vectors91, and plant 
parasitic nematodes203.  The first commercially available agricultural product using an 
RNAi construct is a transgenic corn line204, expected to reach the market prior to 2020, 
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and proof-of-concept studies exist for other crop species as well205.  In the prior example, 
a host crop species is transformed with a transgenic construct that encodes a dsRNA 
specific to a major pest.   Though seemingly simple and elegant in execution, immense 
investments of both capital and labor are required for the development of transgenic 
crops, and the regulatory and social hurdles for the adoption of these crops are limit their 
use to specific countries.  Further, the precise specificity of RNAi means that new 
constructs must be generated for each target species, and new lines generated for each 
crop bearing the transgene.  Transgene constructs will likely remain the preferred method 
of RNAi delivery for crop species, but key advantages exist for the use of in-vitro 
synthesized dsRNA as pest control agents.  These methods will enable the use of RNAi-
based biological control agents on crop species unamenable to transformation, and also 
allow for the targeting of numerous pests without the development of new transgenic 
strains.  In spite of this flexibility, it seems highly unlikely that in-vitro synthesized 
dsRNA alone, commonly referred to as naked dsRNA, will see much application in 
agricultural settings.  dsRNA is known to degrade extremely rapidly in the 
environment52, and is poorly assimilated and rapidly degraded by many destructive insect 
species76.  These deficits represent an enormous barrier to the widespread adoption of in-
vitro RNAi technologies.  However, solutions to these problems are a ripe and active area 
of research.  A wealth of work in this area has already been conducted in the context of 
therapeutic RNAi, and many of these solutions can be applied to the context of 
agricultural RNAi as well.  A frequently employed method to overcome these limitations 
is complexation of dsRNA with a nanocarrier.  The nanocarrier serves to protect dsRNA 
from nucleases206, and can alter the mechanisms by which dsRNA is assimilated into 
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cells207.  In spite of this interest, there is a dearth of studies that have investigated the role 
of environment on the efficacy of gene silencing nanomaterials.  Many studies have 
investigated the role of nanomaterial structure and physical properties on cellular 
uptake208, 209, but these are mostly conducted using cell culture methods with an emphasis 
toward therapeutic ends.  Further, the vast majority of research on agricultural RNAi has 
focused upon the development of knockdown targets210, 211, 212, rather than delivery 
improvement.  In an agricultural setting, delivery of dsRNA will be dependent not only 
on the cellular process of the target organism, but also on environmental interactions 
prior to ingestion.  These interactions have been poorly studied. 
In order to address this lack of knowledge, we have developed the following study 
of the efficacy of chitosan/dsRNA polyplex nanoparticles under differing environmental 
conditions, using a soil-dwelling model organism, Caenorhabditis elegans.   In studying 
RNAi, C. elegans possesses a unique set of characteristics that make it the ideal organism 
for both cellular processes and environmental studies related to RNAi.  C. elegans is the 
first organism in which RNAi was described3 and, consequently, possesses the most 
detailed descriptions of RNAi cellular mechanisms33, 171, 213 and uptake25, 26, 30.  In 
addition to this, RNAi response in C. elegans can be triggered by oral ingestion of 
dsRNA117.  This allows for the development of a feeding assay that is an approximation 
of field conditions to be encountered in agricultural settings.  Finally, thanks to the 
abundance of transgenic strains of C. elegans available, we are able to target green 
fluorescent protein (GFP) to allow rapid, objective assessment of RNAi efficacy. 
Of the classes of materials suitable for complexation with dsRNA, among the 
most studied and most promising are polycationic polymers214, 215, 216.  In this particular 
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model, the anionic phosphate backbone of dsRNA has an electrostatic interaction with 
the cationic groups of the polymer.  Under conditions specific to each system, this 
interaction results in the formation of stable polyplex nanoparticles (PNs).  A vast amount 
of research has been conducted on polycation/nucleic acid complexes, in a search for 
high efficiency217, 218, 219 and low toxicity121, 220, 221 therapeutics.  Chitosan (poly β-1,4-D-
glucosamine) in particular has been the subject of much investigation, owing to its 
inexpensive manufacture from marine waste123, low toxicity124, and wide variety of 
molecular weights and modifications available125.  Several chitosan-based materials for 
gene silencing have already been tested in insect species92, 170, and applications of 
chitosan in other areas of agricultural management have been identified130, 222, 223. 
In our recent work, we discovered several characteristics of chitosan/dsRNA PNs 
that were previously unknown.  Principally, we found that in C. elegans, chitosan/dsRNA 
PNs are more potent than naked dsRNA on a whole body concentration basis, and that 
these particles are assimilated outside the canonical dsRNA uptake pathway207.  To 
expand upon this work, we have investigated the efficacy of chitosan/dsRNA PNs while 
altering environmental variables.  We exposed C. elegans to chitosan/dsRNA PNs while 
altering pH, competitive anions (nitrate and phosphate), and natural organic matter 
(NOM) content in exposure solutions.  We selected concentrations of these constituents 
that are possible in an agricultural setting to preserve a realistic exposure scenario as 
closely as possible224, 225, 226.  Subsequently, we characterized some of the physical 
changes that occur in chitosan/dsRNA PNs under these varying conditions, in an attempt 
to correlate environment, nanomaterial structure, and gene silencing.  We hypothesized 
that as we increased pH, the efficacy of PNs would decline, due to aggregation.  
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Similarly, we expected that competitive anions would occupy binding sites on cationic 
chitosan, and eventually displace the dsRNA as well, leading to a reduction in 
effectiveness.  Given the highly negative charge of NOM, we speculated that PNs would 
be sequestered and rendered unavailable to C. elegans, completely eliminating efficacy as 
NOM concentration increases. 
3.4 Methods 
3.4.1 C. elegans Maintenance 
C. elegans strains N2 and CGC4 (umnTi1 III [eft-3p::GFP + unc-119(+)]) were 
maintained on K-medium agar plates seeded with OP50 Escherichia coli at 20°C, 
according to established methods180.  CGC4 is a transgenic strain produced using the 
MosSCI system227, which possesses a single copy of GFP at a known location in the 
genome, driven by a translation elongation promoter eft-3p228. 
3.4.2 dsRNA Preparation and Polyplex Synthesis 
Genomic DNA was isolated from C. elegans using phenol-chloroform and 
ethanol precipitation using established methods181.  Templates for dsRNA synthesis were 
generated from genomic DNA using PCR by including primers with an appended T7 
promoter sequence181 (Table S1).  Templates were purified using a Qiagen PCR Cleanup 
Kit (28104, Germantown, MD, USA), and eluted in 18.2 M Ω H2O (DI).  dsRNA was 
generated using a ThermoFisher Scientific TranscriptAid T7 High Yield Transcription 
Kit (K0441, Waltham, MA, USA) according to the manufacturer’s instructions, and 
purified using phenol-chloroform followed by ethanol precipitation181 and resuspension 
in DI.  To prepare Alexa Fluor 488 labeled dsRNA, dsRNA was synthesized as above, 
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with the addition of 5-(3-aminoallyl)-UTP (ThermoFisher Scientific AM8437, Waltham, 
MA, USA) as per the manufacturer’s instructions.  Aminoallyl-dsRNA was labeled using 
Alexa Fluor 488 NHS Ester (ThermoFisher Scientific A20000, Waltham, MA, USA), 
according to the manufacturer’s protocol.  Labeled dsRNA was separated from unreacted 
fluorophore using size exclusion chromatography spin columns (BioRad 7326223, 
Hercules, CA, USA).  Reaction yield was confirmed by measuring absorbance at 260 nm 
using a Varian Cary 50 Bio UV-Vis Spectrophotometer equipped with a Hëllma TrayCell 
(Hëllma USA, Plainview, NY USA).  Typically, a single reaction would yield 150 μg of 
dsRNA.  Polyplexes were prepared using our previously described method207, itself a 
modification of the Zhang method92.  A 0.58% solution of low molecular weight chitosan 
(Polysciences 21161, Warrington, PA, USA) was prepared in 0.2 M acetate buffer at pH 
4.5.  dsRNA was diluted to 1 μg/μL in 50 mM Na2SO4, and combined with an equal 
volume of chitosan solution by pipetting.  The solution was then immediately heated in a 
water bath at 55°C for 1 minute, and then vigorously vortexed for 30 seconds, resulting in 
the formation of polyplex nanoparticles. 
3.4.3 Transmission Electron Microscopy 
Samples were prepared by diluting chitosan/dsRNA polyplex to ~50 mg/L in 
unamended MHRW229.  Copper grids coated with lacey formvar/carbon (Ted Pella 
01883-F, Redding, CA, USA) were then dipped in the sample, and dried overnight in a 
desiccator.  Electron micrographs were captured using a ThermoFisher Scientific Talos 
F200X S/TEM with a field emission gun operating at 200 keV, and a Ceta 16 megapixel 
CCD sensor.  Energy-dispersive X-ray spectroscopy mapping was performed in STEM 
mode, using the Super-X EDS system. 
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3.4.4 Exposure Media Preparation 
For all exposures, the base medium was moderately hard reconstituted water 
(MHRW)229.  For exposures where pH was the independent variable, MHRW was 
supplemented with 1 mM MES and 1 mM MOPS and the pH was adjusted with sulfuric 
acid (pH 5, 6, and 7) or sodium hydroxide (pH 8).  For nitrate and phosphate MHRW 
solutions, exposure solutions were prepared with 1 M stock solutions of sodium nitrate or 
monobasic sodium phosphate, and the pH was subsequently adjusted to 6 with sulfuric 
acid.  Solutions were prepared such that the final concentration indicated in results would 
be present following addition of polyplex and nematodes.  Natural organic matter 
solutions were prepared similarly, from a 500 mg/L stock solution of Pahokee peat humic 
acid (PPHA; International Humic Substances Society, St. Paul, MN, USA), with a 
subsequent adjustment of the pH to 6 with sulfuric acid. 
3.4.5 Polyplex Exposures and Imaging 
Caenorhabditis elegans were age synchronized using sodium hydroxide and 
sodium hypochlorite according to established methods180, and allowed to hatch on OP50 
E. coli seeded K-medium agar plates.  After 24 hours, young nematodes were washed 
from plates with K-medium and placed in 15 mL polypropylene centrifuge tubes.  
Nematodes were then centrifuged at 160 x g, and the supernatant removed.  The medium 
was replaced with a solution of 25% moderately hard reconstituted water (MHRW)229 
and 75% K-medium, and incubated at 20°C for 15 minutes.  This process was repeated 
three additional times, with 25% stepwise increases of MHRW concentration until the 
final concentration was 100% MHRW.  For exposures, 2 μL of compact nematode pellet 
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(~50 worms) was placed in 0.2 mL PCR tubes containing the indicated exposure medium 
and 100 ng/μL dsRNA as either naked dsRNA or chitosan/dsRNA PN, to a total volume 
of 20 μL.  Control exposures were simultaneously conducted using DI in lieu of dsRNA.  
All exposures were conducted in triplicate.  Tubes with nematodes and exposure medium 
were then incubated for 24 hours at 20°C.  For imaging, an 8 μL drop of exposure media 
and nematodes was placed on a microscope slide.  Nematodes were then anesthetized 
with 2 μL 50 mM levamisole and secured with a coverslip.  Imaging was performed 
using a Nikon Eclipse 90i microscope equipped with Nikon Intensilight C-HGFI 
Epifluorescence Illuminator, a Nikon GFP filter cube, and a Nikon DS-Qi1Mc camera 
(Tokyo, Japan).  Multichannel images of individual nematodes were taken at 20x 
magnification, consisting of DIC (autoexposure) and fluorescence (5s exposure) images.  
Five nematodes were imaged per exposure replicate.  The generated images were then 
processed using the image analysis software Fiji185.  First, the background was subtracted 
from the GFP channel of each image using the rolling ball method with a radius of 50 
pixels.  Next, a region of interest was drawn around each nematode using the DIC image, 
and the mean pixel intensity was measured.  The mean pixel intensity of five nematodes 
was averaged per replicate, and the mean of the replicates is the reported pixel intensity. 
3.4.6 Dynamic Light Scattering, Phase Analysis Light Scattering, and Fluorescence 
Correlation Spectroscopy 
Chitosan/dsRNA PNs were prepared as above, using Alexa Fluor 488 labeled 
dsRNA.  Exposure solutions were then prepared using the same indicated environmental 
variables, replacing the worm pellet volume with MHRW.  Samples were then diluted 
10X in MHRW with the appropriate indicated amendments. 
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Dynamic light scattering (DLS) and phase analysis light scattering (PALS) 
measurements were taken using a Malvern Zetasizer Nano ZS at 25°C, using polystyrene 
cuvettes for DLS (Malvern Panalytical DTS0012, Westborough, MA, USA) and folded 
capillary cells for PALS (Malvern Panalytical DTS1070, Westborough, MA, USA).  For 
the PALS measurements, zeta potential is reported using the Hückel approximation. 
Fluorescence correlation spectroscopy measurements were taken using an ISS 
Alba FCS instrument, with a Nikon Eclipse Ti-U inverted confocal microscope and a 
PlanAPO 1.2 NA 60X water immersion objective serving as the optical apparatus.  The 
laser intensity (488 nm) and pinholes (50 μm) were calibrated using Rhodamine 110 dye 
in water.  Data was collected using the ISS VistaVision software package.  The diffusion 
coefficient was derived from the autocorrelation function of each sample230, and the 
hydrodynamic diameter was calculated using the Stokes-Einstein equation231. 
3.4.7 Statistical Analysis 
Comparisons between treatments in C. elegans experiments, DLS, FCS, and zeta 
potential measurements were conducted using PROC GLM in SAS 9.4.  The Student-
Newman-Keuls procedure with α=0.1 was used as a post-hoc test for multiple 
comparisons. 
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3.5 Results 
3.5.1 Transmission Electron Microscopy 
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Figure 3.1 – Energy-dispersive X-ray Spectroscopy (EDS) maps and bright-field images 
of chitosan/dsRNA polyplex nanoparticles.  A – High angle annular dark field image of a 
chitosan/dsRNA polyplex nanoparticle aggregate, operating in STEM mode.  B – EDS 
map of nitrogen localization.  C – EDS map of phosphorus localization.  D – Merged 
EDS mapping of nitrogen and phosphorus localization.  E, F – Bright-field images of 
chitosan/dsRNA polyplex nanoparticles and aggregates. 
 There is broad colocalization of nitrogen and phosphorus within the 
chitosan/dsRNA PN (Fig. 3.1), suggesting that what is shown is indeed a polyplex 
nanoparticle composed of dsRNA and chitosan.  High concentrations of oxygen and 
carbon are also present within the particle, as would be expected of a polysaccharide 
based material (Fig. 3.1).  There is also a wide distribution of particle sizes and 
morphologies present in the solution, with diameters ranging from ~100-300 nm for 
individual particles, and 1-2 um for aggregates.  The morphologies range from nearly 
spherical to more amorphous and globular (Fig. 3.1E, 3.1F). 
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Figure 3.2 – Gene expression knockdown (as measured by GFP fluorescence intensity) 
and physical properties of chitosan/dsRNA polyplex nanoparticles under varying pH 
conditions in moderately hard reconstituted water.  Treatments with the same letter are 
not statistically different (n = 3, α < 0.1).  A – Mean fluorescence of CGC4 
Caenorhabditis elegans exposed to 100 ng/μL chitosan/dsRNA polyplexes and dsRNA 
under varying pH.  Values represent the mean of 5 nematodes in individual exposure 
groups.  B – Zeta potential of chitosan/dsRNA polyplexes under varying pH.  C – Mass 
weighted hydrodynamic diameter (Dh) of chitosan/dsRNA polyplexes as determined by 
fluorescence correlation spectroscopy.  D – Intensity weighted Z-Average hydrodynamic 
diameter of chitosan/dsRNA polyplexes as determined by dynamic light scattering. 
 59 
 
 
Figure 3.3 - N2 Caenorhabditis elegans exposed to 100 ng/μL chitosan/Alexa Fluor 488 
labeled dsRNA polyplex nanoparticles under varying pH conditions.  Insets are 
differential interference contrast (DIC) images of the corresponding fluorescent channel.  
Areas showing ingestion of polyplex nanoparticles are circled in red. 
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3.5.2 Influence of pH on chitosan/dsRNA polyplex nanoparticle bioactivity 
The pH value of the medium influences the efficacy of chitosan/dsRNA PNs.  In 
every exposure scenario, naked dsRNA is effective at gene knockdown (Fig. 3.2A).  At 
pH 5 and 6, chitosan/dsRNA PNs are equally effective as naked dsRNA at gene 
knockdown, a result consistent with our earlier work.  At pH ≥7, the efficacy of PNs for 
gene knockdown declines (Fig. 3.2A).  Zeta potential measurements show that 
chitosan/dsRNA PNs possess a positive zeta potential at pH ≤ 7, and are nominally 
uncharged at pH 8 (Fig. 3.2B).  DLS measurements of chitosan/dsRNA PN 
hydrodynamic diameters range from 500-650 nm (Fig. 3.2D), with no statistical 
difference among the treatments.  The particle diameter measured using FCS was much 
smaller than with DLS (Fig. 3.2C), though this is to be expected given that FCS 
measurements are by definition mass weighted230 and our reported DLS measurements 
are intensity weighted232.  Some differences in particle size are present between 
treatments.  There is a statistical difference between the pH 6 samples and the pH 7 
samples, though this can largely be accounted for the high degree of variability in the pH 
7 treatment.  In spite of these differences, the overall difference between particle 
diameters is comparatively small, with the mean of all treatments falling between 50 and 
150 nm.  In all treatments, there is evidence that the fluorescently labeled 
chitosan/dsRNA PNs are ingested by C. elegans (Fig. 3.3). 
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3.5.3 Influence of inorganic anions on chitosan/dsRNA polyplex nanoparticle bioactivity 
 
Figure 3.4 - Gene expression knockdown (as measured by GFP fluorescence intensity) 
and physical properties of chitosan/dsRNA polyplex nanoparticles under varying 
inorganic nitrate concentrations in moderately hard reconstituted water.  Treatments with 
the same letter are not statistically different (n = 3, α < 0.1).  A – Mean fluorescence of 
CGC4 Caenorhabditis elegans exposed to 100 ng/μL chitosan/dsRNA polyplexes and 
dsRNA under varying phosphate concentrations.  Values represent the mean of 5 
nematodes in individual exposure groups.  B – Zeta potential of chitosan/dsRNA PN 
under varying phosphate concentrations.  C – Mass weighted hydrodynamic diameter 
(Dh) of chitosan/dsRNA polyplexes as determined by fluorescence correlation 
spectroscopy.  D – Intensity weighted Z-Average hydrodynamic diameter of 
chitosan/dsRNA polyplexes as determined by dynamic light scattering. 
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Figure 3.5 - Gene expression knockdown (as measured by GFP fluorescence intensity) 
and physical properties of chitosan/dsRNA polyplex nanoparticles under varying 
inorganic phosphate concentrations in moderately hard reconstituted water.  Treatments 
with the same letter are not statistically different (n = 3, α < 0.1).  A – Mean fluorescence 
of CGC4 Caenorhabditis elegans exposed to 100 ng/μL chitosan/dsRNA polyplexes and 
dsRNA under varying nitrate concentrations.  Values represent the mean of 5 nematodes 
in individual exposure groups.  B – Zeta potential of chitosan/dsRNA polyplexes under 
varying nitrate concentrations.  C – Mass weighted hydrodynamic diameter (Dh) of 
chitosan/dsRNA polyplexes as determined by fluorescence correlation spectroscopy.  D – 
Intensity weighted Z-Average hydrodynamic diameter of chitosan/dsRNA polyplexes as 
determined by dynamic light scattering. 
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Figure 3.6 - N2 Caenorhabditis elegans exposed to 100 ng/μL chitosan/Alexa Fluor 488 
labeled dsRNA polyplex nanoparticles at the maximum phosphate and nitrate conditions.   
Insets are differential interference contrast (DIC) images of the corresponding fluorescent 
channel.  Areas showing ingestion of polyplex nanoparticles are circled in red. 
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None of the experiments where inorganic phosphate and nitrate were varied 
resulted in a failure of knockdown for either naked dsRNA or chitosan/dsRNA PNs (Fig. 
3.4A, 3.5A).  Hydrodynamic diameter measurements by FCS show that particles in all 
treatments are approximately the same size, on the order of 100-150 nm (Fig. 3.4C, 
3.5C).  Though there are some differences in the hydrodynamic diameter of PNs 10 mg/L 
and 20 mg/L NO3 treatments, the magnitude of these differences is small.  Hydrodynamic 
diameter measurements by DLS were similar, in that particles were roughly the same 
diameter within treatments (Fig. 3.4D, 3.5D).  Zeta potential is substantially reduced 
compared to the low pH samples (Fig 3.4B, 3.5B, 3.2B), but is still positive.  
Fluorescence imaging with chitosan/Alexa Fluor 488 labeled dsRNA PNs at the highest 
concentrations of phosphate and nitrate (Fig. 3.6) clearly shows that in both cases, PNs 
are internalized by C. elegans. 
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3.5.4 Influence of Natural Organic Matter on chitosan/dsRNA polyplex nanoparticle 
bioactivity  
Figure 3.7 - Gene expression knockdown (as measured by GFP fluorescence intensity) 
and physical properties of chitosan/dsRNA polyplex nanoparticles under varying humic 
acid concentrations in moderately hard reconstituted water.  Treatments with the same 
letter are not statistically different (n = 3, α < 0.1).  A – Mean fluorescence of CGC4 
Caenorhabditis elegans exposed to 100 ng/μL chitosan/dsRNA polyplexes and dsRNA 
under varying natural organic matter concentrations.  Values represent the mean of 5 
nematodes in individual exposure groups.  B – Zeta potential of chitosan/dsRNA 
polyplexes under varying natural organic matter concentrations.  C – Intensity weighted 
Z-Average hydrodynamic diameter (Dh) of chitosan/dsRNA polyplexes as determined by 
dynamic light scattering.  D – Visible aggregates present in the humic acid/polyplex 
solutions. 
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Figure 3.8 - N2 Caenorhabditis elegans exposed to 100 ng/μL chitosan/Alexa Fluor 488 
labeled dsRNA polyplex nanoparticles and Pahokee peat humic acid.  Insets are 
differential interference contrast (DIC) images of the corresponding fluorescent channel.  
A – 2.5 mg/L humic acid; B – 5 mg/L humic acid; C – 10 mg/L humic acid; D – 20 mg/L 
humic acid; E – 50 mg/L humic acid 
 As in the previous experiments, no treatment level of NOM affected gene 
knockdown by naked dsRNA (Fig. 3.7A).  At low concentrations (≤ 2.5 mg/L) of NOM 
(Fig. 3.7A), chitosan/dsRNA PNs are effective.  However, at all concentrations tested 
beyond that, knockdown is absent and PN treatments are statistically indistinguishable 
from controls.  As with all previously discussed experiments, particle size does not 
appear to be a factor in knockdown efficacy (Fig. 3.7C), though we are only able to 
estimate size from DLS, since fluorescence from NOM complicated FCS 
measurments233.  Between concentrations of 2.5 and 5 mg/L, there is a charge reversal, 
from positive to negative, in the zeta potential measurements (Fig. 3.7B).  We also 
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observe the presence of large aggregates in each of the samples that are visible to the 
naked eye (Fig. 3.7D).  As the concentration of humic acid increases, so does the 
coloration of the aggregates.  At low concentrations of humic acid, images using 
chitosan/Alexa Fluor 488 dsRNA PNs are similar to those in other, effective exposures 
(Fig. 3.8A, 3.8B, 3.8C), though we were unable to find evidence of internalized PNs.  
PNs still adhere to the C. elegans cuticle.  It is worth noting that high concentrations of 
humic acid complicate fluorescence microscopy due to quenching, as determined by our 
own observations (Fig. 3.9) and those of others234, 235.  However, the quenching we 
observed was moderate (Fig 3.9). 
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Figure 3.9 – Quenching of AlexaFluor 488 fluorescence by humic acid.  AlexaFluor 488 
labeled dsRNA and chitosan/dsRNA polyplexes were added to moderately hard 
reconstituted water (MHRW) amended with the indicated concentration of Pahokee peat 
humic acid, and fluorescence intensity was measured (Ex = 490 nm; Em = 525 nm).  
Background fluorescence from MHRW/humic acid blanks were subtracted from the 
corresponding measurement. 
3.6 Discussion 
The principal aim of this study was to characterize the ability of chitosan/dsRNA 
PNs to silence genes under different chemical conditions.  Of our tested conditions, high 
pH and modest concentrations of natural organic matter impede PN efficacy.  PN efficacy 
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is unaffected by anion concentration or low pH.  Initially, we believed there were several 
different phenomena that could explain a lack of chitosan/dsRNA PN efficacy for any 
given treatment.  One possibility we thought highly likely is that the particles are unstable 
at high pH or ionic strength and may aggregate to the extent that they are unavailable to 
C. elegans. The adult C. elegans pharynx is estimated to be approximately 1 μm in 
diameter, but can stretch to allow passage of larger particles, on the order of 4-5 μm236.  It 
is quite clear from fluorescence imaging and hydrodynamic diameter measurements that 
this is not a likely explanation for samples which did not show gene knockdown, in the 
case of the pH exposures.   
The FCS measurements found a much smaller hydrodynamic diameter than the 
DLS measurements.  This is expected, since DLS is based on fluctuations in scattered 
light and FCS is based on fluctuations of fluorescence of the particles.  Scattering of light 
dramatically increases with the radius of the particle (related to the r6), thus in DLS, the 
presence of a few large particles greatly increases the intensity weighted average 
hydrodynamic diameter.  The FCS measurements do not have this bias as particles are 
represented based on the amount of fluorescent label in the particles which is related to 
particle mass.   At pH 8, the FCS measurement showed an increase in particle size while 
the DLS measurement didn’t.  This could be attributable to a lower isoelectric point of 
dsRNA-chitosan PNs relative to chitosan only particles.  If this were the case, the PNs 
would aggregate at pH 8, but not the chitosan only particles.  This would be consistent 
with the observed differences between the FCS and DLS data, since FCS only detects 
particles containing the fluorescently labelled dsRNA.   
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Our fluorescence microscopy studies clearly show that C. elegans are capable of 
internalizing chitosan/dsRNA PNs under all of the studied pH conditions.   Also, the C. 
elegans gut is consistently acidic189, which would imply that PNs have a similar positive 
charge while passing the digestive tract.  However, if dsRNA desorbs from the chitosan 
in the medium, as suggested by FCS and DLS data, then one would expect the efficacy of 
the dsRNA to decrease given that the chitosan/dsRNA PN is more effective at gene 
knockdown than naked dsRNA. 
  The driver of gene silencing failure in our NOM experiments is likely interactions 
between cationic chitosan and anionic humic acid, through aggregation and removal of 
PNs.  Under native synthesis conditions, chitosan/dsRNA PNs possess a positive zeta 
potential.  An abundance of chitosan (pKa 6.5)237 at the particle surface, as observed in 
our STEM elemental mapping, would account for the highly positive zeta potential of 
chitosan/dsRNA PNs at pH < 6, and also the reduction of zeta potential as pH increases.  
Interactions between polyplex surfaces and organic matter would be expected and could 
cause neutralization of the positive charge and bridging between particles leading to 
extensive aggregation.  We have previously observed that NOM causes aggregation and 
decreased uptake of positively charged diethylaminoethyldextran coated CeO2 particles 
in C. elegans152.  This is evidenced by the charge reversal observed above 2.5 mg humic 
acid/L.  This is confirmed in our fluorescence imaging studies with humic acid, where at 
20 mg/L and higher, only large aggregates are present in solution.  Previous studies that 
have investigated the effects of natural organic matter on nanoparticle-biota interactions 
have generally found that biological effects such as toxicity152, 238 tend to be decreased by 
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the presence of NOM.  From this study, it is clear that this phenomenon is true for 
cationic PNs as well.   
Notably, naked dsRNA effectively silences genes in most of the exposure scenarios 
we investigated, with some variability at various concentrations.  The phosphate 
backbone of dsRNA gives it an essentially permanent anionic character, which would 
limit interactions with NOM and inorganic anions.  Though dsRNA specific transporters 
are known to have a pH dependence for effective binding of substrates239, the pH of the 
C. elegans gut is tightly regulated, as discussed earlier, thus accounting for the lack of 
any change in gene silencing based upon exposure media pH. 
3.7 Conclusions 
 In this work, we have identified factors that will likely play into the efficacy of 
chitosan-dsRNA PNs in agricultural settings.  We conclude that is unlikely that inorganic 
ions will influence stability, degradation, or bioactivity of such materials.  Rather, 
environmental pH and interactions with substrates such as natural organic matter will be 
the dominant factors that must be considered.  Through the use of higher pKa polymers, 
it is quite possible that inactivity due to high pH could be avoided, though this will need 
to be balanced with the increased toxicity associated with most other polycations121.  
Other means will have to be employed to avoid the much more promiscuous interactions 
with natural biomolecules, such as microencapsulation240.  Though investigations into 
gene silencing nanomaterials as biological control agents are comparatively new, we 
must again stress the importance of realistic exposure scenarios, particularly as it relates 
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to the use of materials that will be employed in the endless complexity of the natural 
environment. 
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Entomology, University of Kentucky; 3Aix Marseille University, CNRS, IRD, INRA 
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4.1 Abstract 
 RNA interference is a promising crop protection technology that has seen rapid 
development in the past several years.  Though the majority of these applications utilize 
transgenic organisms bearing double-stranded RNA constructs, the use of in-vitro 
synthesized double-stranded RNA has numerous advantages.  When used in agricultural 
settings, double-stranded RNA will necessarily be used with delivery vehicles such as 
nano-scale polymers and particles to reduce unwanted degradation, improve environmental 
persistence, and increase uptake in target organisms.  Though extensively researched in 
therapeutic contexts, little work has explored the use of nano-scale substrates for delivery 
of dsRNA for agricultural purposes.  Here, we have investigated polyamino acids and solid 
core nanomaterials for delivery of dsRNA and efficacy of gene knockdown using the model 
nematode Caenorhabditis elegans.  Of the materials investigated, only Mg-Al layered 
double-hydroxide nanoparticles were effective at gene knockdown in Caenorhabditis 
elegans.  In addition, we identified previously unreported injuries to the mouthpart of C. 
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elegans associated with the use of a common gene delivery polymer, poly-L-arginine.  The 
information collected herein will allow the pursuit of further research into promising 
materials for dsRNA delivery, and also allow for the exclusion of those will little efficacy 
or deleterious effects. 
4.2 Introduction 
 RNA interference is an endogenous system in eukaryotes that selectively degrades 
messenger RNA (mRNA) by use of a double-stranded RNA (dsRNA) template3.  The 
depletion of these mRNAs leads to a reduction in transcription of the associated gene, 
and ultimately leads to ‘gene silencing’.  By introducing specific, synthetic dsRNA 
molecules, genes can be selectively knocked down.  RNAi has found an essential role in 
the modern molecular biology laboratory as a tool for reverse genetics and the study of 
gene function241, 242, 243.  Thousands of studies in all major classifications of eukaryotes244 
have utilized RNAi for an astoundingly broad variety of biological work.  Though the 
theoretical and research benefits of RNAi cannot be overstated, practical applications of 
RNAi exist as well, particularly in agriculture245, 246, 247.  Early studies into the insecticidal 
potential of RNAi determined that transgenic plants bearing a dsRNA transcribing 
construct were capable of controlling insect pests161.  In many ways, RNAi represents an 
ideal environmentally friendly pesticide.  Traditional small molecule insecticides are 
often highly toxic to non-target organisms, including humans248.  Though modern 
insecticides, such as pyrethroids and neonicotinoids, are generally less toxic than their 
precursors to mammals, significant toxicity exists to other organisms, such as birds and 
fish249, 250.  Another issue that has plagued synthetic insecticides since their introduction 
is environmental persistence.  Organohalides are particularly notable in this regard and 
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continue to remain in the environment at detectable concentrations in spite of the 
discontinuation of their use decades ago251.  RNAi insecticides mitigate both of these 
problems.  In order to cause any effect, the sequence homology between the target 
mRNA sequence and a synthetic dsRNA must be extremely close.  Even a few base pair 
differences will render a given dsRNA ineffective252.  This imparts an extreme specificity 
to RNAi based biological control agents, in that only organisms in the same genus as the 
target are likely to be affected by a well-designed dsRNA sequence202.  In addition to 
this, dsRNA is extraordinarily labile in natural environments.  Estimates for the 
degradation time of dsRNA in soils is less than 48 hours52, and less than three days in 
aquatic environments53.  The vast potential of RNAi has incentivized the development of 
products that take advantage of these benefits.  The first commercial product that uses 
RNAi crop protection, a line of corn that possesses a dsRNA construct targeting western 
corn rootworm159, 253, is expected to be released in 2020.  In addition to these advantages, 
resistance to earlier biotechnology based insect control methods, such as Bt toxin bearing 
transgenic crops, is an emerging threat254.  Thus, the impetus for development of RNAi 
based insecticides has never been greater. 
 Current development of RNAi insecticides has principally focused upon 
transgenic constructs62, 83, 255.  Though effective, this method is limited in that new 
constructs and transgenic lines must be generated for each pest in each crop, an 
exceedingly expensive and time-consuming process.  Furthermore, the regulatory hurdles 
for the approval of transgenic crops are immense in many countries, and their use is 
forbidden in many others.  A far more flexible solution is the synthesis of dsRNA in-vitro 
for use as a surface treatment50. 
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 In our previous work, we identified that chitosan/dsRNA polyplex nanoparticles 
(PNs) are as effective as naked dsRNA at gene silencing in C. elegans, with the ability to 
evade the usual mechanisms of dsRNA uptake and enter cells via clathrin-mediated 
endocytosis207.  Concurrently, we identified a notable side effect of chitosan exposure in 
C. elegans, suppression of myosin expression.  Later, we further developed this work by 
investigating the ability of chitosan/dsRNA PNs to silence genes in C. elegans under 
varying environmental conditions.  Our findings indicated that these particles are 
rendered ineffective at high pH and in the presence of high molecular weight natural 
organic matter (NOM).  Given the limitations of chitosan, we have tested several other 
nanocarriers in C. elegans as candidates for dsRNA delivery.  We selected materials that 
are deliberately diverse in chemical and physical properties so that if any intrinsic 
property associated with a given material assists in gene knockdown efficiency, it can be 
identified.  In addition, we selected materials that are simple and inexpensive, permitting 
future use at scales necessary for field deployment.  Of the materials tested, two are 
cationic amino acid homopolymers (poly-L-lysine256 and poly-L-arginine257), two are 
synthetic cationic nanomaterials (Mg-Al layered double hydroxide258 and Ge doped 
imogolite259) and the last is a polymer-solid core composite (Poly-L-arginine 
functionalized Au)260.  Gold nanoparticles were selected due to their extensively studied 
shape and size controls, and to serve as a model system within the study.  The polyamino 
acids were selected due to their high pKas (~10.5 for lysine and ~12.5 for arginine), 
which we hypothesized would increase efficacy in high pH environments and improve 
stability.  LDH and imogolite were selected for Each of these was characterized with and 
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without the addition of dsRNA, knockdown measured using a reporter strain of C. 
elegans, and uptake monitored using fluorescently labeled dsRNA. 
4.3 Methods 
4.3.1  C. elegans Maintenance 
 C. elegans strains N2 (wildtype), CGC4 (umnTi1 III [eft-3p::GFP + unc-
119(+)]), EG7987 (oxTi416 [eft-3p::mCherry::tbb-2 3'UTR + Cbr-unc-119(+)], and 
HC196 (sid-1(qt9)) were maintained on 10 cm K-Agar plates seeded with E. coli strain 
OP50 at 20°C.  CGC4 and EG7987 are transgenic strains produced using the MosSCI 
system227, which possesses a single copy of GFP or mCherry respectively at a known 
location in the genome, driven by the translation elongation promoter eft-3p228.  
Additionally, EG7987 possesses the tbb-2 (tubulin) 3’UTR261 to regulate germline 
expression. 
4.3.2  dsRNA and Fluorescently Labeled dsRNA Synthesis 
 Templates for generation of dsRNA were synthesized using PCR and primers 
specific for GFP and mCherry with T7 promoter termini (Table S1), with CGC4 and 
EG7987 genomic DNA serving as the PCR templates, respectively181.  T7 templates were 
purified using the Qiagen PCR Purification Kit (28104, Germantown, MD, USA), and 
resuspended in 18.2 M Ω deionized H2O (DI).  dsRNA was synthesized using the 
Thermo Scientific TranscriptAid T7 High Yield Transcription Kit (K0441, Waltham, 
MA) according to manufacturer’s instructions.  To synthesize aminoallyl-dsRNA (AA-
dsRNA), the TransciptAid T7 kit was used as above with the GFP T7 template, but with 
the inclusion 5-(3-aminoallyl)-UTP (ThermoFisher Scientific AM8437, Waltham, MA, 
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USA) as per the manufacturer’s instructions.  All dsRNA solutions were purified using 
phenol-chloroform and ethanol precipitation181.  dsRNA and AA-dsRNA were 
subsequently diluted in DI and stored at -20°C.  Reaction yield and final concentration 
were determined by measuring absorbance at 260 nm using a Varian Cary 50 Bio UV-Vis 
Spectrophotometer equipped with a Hëllma TrayCell (Hëllma USA, Plainview, NY 
USA).   
 Alexa Fluor 488-dsRNA was synthesized using AA-dsRNA and Alexa Fluor 488 
NHS ester (ThermoFisher Scientific A20000, Waltham, MA, USA) according to the 
manufacturer’s instructions.  mCherry dsRNA was labeled with cy3 using the Silencer 
siRNA Labeling Kit (ThermoFisher Scientific AM1632, Waltham, MA, USA) according 
to the manufacturer’s instructions.  Fluorescently labeled dsRNA was stored in DI at -
20°C, in foil-wrapped 1.5 mL microcentrifuge tubes.  The final concentration was 
determined as described above. 
4.3.3 Transmission Electron Microscopy 
Transmission electron micrographs were captured using a Thermo Fisher 
Scientific Talos F200X scanning transmission electron microscope operating at 200kV.  
Samples were prepared using formvar/lacey carbon-coated copper grids (Ted Pella 
01811, Redding, CA, USA). 
4.3.4 dsRNA Binding and Gel Retardation Assays 
To determine binding affinity between nanocarriers and dsRNA, binding assays 
were performed for each material.  For each, 100 μL of a 50 ng/μL dsRNA solution was 
added to 100 μL of nanomaterial or polymer under vigorous vortexing.  Nanomaterial 
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concentrations were varied such that the mass ratio of nanomaterial:dsRNA fell between 
1 and 10.  Following 30 minutes of incubation at room temperature, polymer-dsRNA 
solutions were centrifuged at 16873 xg for one hour.  dsRNA concentration in the 
supernatant was measured a Nanodrop 200 spectrophotometer (Thermo-Fisher Scientific, 
Waltham, MA, USA).  Binding percent was calculated using the formula: 
(𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑀𝑀𝑇𝑇𝑑𝑑𝑑𝑑−𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑇𝑇𝑇𝑇𝑇𝑇𝑆𝑆𝑇𝑇 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑀𝑀𝑇𝑇𝑑𝑑𝑑𝑑)
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑀𝑀𝑇𝑇𝑑𝑑𝑑𝑑
∗  100% 
Gel retardation assays were performed using alkaline gel electrophoresis in tris 
borate EDTA buffer181.  Following incubation at room temperature, dsRNA/nanomaterial 
solutions were filtered using Amicon® Ultra 50 kDa cut-off unit filters (Merck Millipore 
Ltd, Tullagreen, IRL).  Retentate pellet was resuspended in 20 μL DI and ran on 1% 
agarose gels with 0.8 μg/mL ethidium bromide.  Gels were run at 100V until band 
separation was apparent in the ladder (Bionexus Hi-Lo DNA Marker, Oakland, CA, 
USA).  Images were collected using a Bio-Rad Gel Doc imaging system. 
4.3.5 Polyplex and Nanoparticle Synthesis/Characterization 
Ideal mass ratios (approaching 100% binding, when possible) were determined 
for each material based upon results derived from binding and gel retardation assays.   
 Poly-L-Lysine (Alamanda Polymers PLKC50, Huntsville, AL, USA) (PLK) and 
Poly-L-Arginine (Alamanda Polymers PLR50, Huntsville, AL, USA) (PLR) were 
suspended in DI at 10 mg/mL and sonicated in a bath sonicator for 10 minutes.  To form 
polyplex nanoparticles, dsRNA or Alexa Fluor 488-dsRNA in DI was added to solutions 
of polyamino acids at a 5:1 polymer:dsRNA mass ratio, dropwise, under vigorous 
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mixing.  Polyplex solutions were then placed on a laboratory rotator and mixed for 10 
minutes. 
 Citrate-coated spherical gold nanoparticles (Nanopartz A11-20-CIT-DIH-100, 
Loveland, CO, USA) were functionalized with PLR by use of a layer-by-layer method.  1 
mL of stock solutions of cit-Au (100 OD) were centrifuged at 16873 x g for 10 minutes 
in each of two 2 mL microcentrifuge tubes.  The supernatant was drawn off and 
discarded, and the pelleted cit-Au was resuspended in 100 μL DI by bath sonication for 2 
minutes, and recombined as a single 200 μL solution.  Concurrently, 80 μL of a 5 mg/mL 
solution of PLR was added to 4 mL DI in a 15 mL conical centrifuge tube, and gently 
vortexed.  While vortexing, the cit-Au was rapidly added to the PLR solution, and 
subsequently allowed to mix on an end to end rotator for 15 minutes.  The resultant 
solution was then divided equally into four 2 mL microcentrifuge tubes, and centrifuged 
at 16873 x g for 10 minutes.  The supernatant was then drawn off and discarded, and the 
pellets were resuspended in 250 μL 18.2 DI each by bath sonication for 2 minutes.  Final 
concentration was estimated by measuring visible light absorbance at 525 nm using a 
Varian Cary 50 Bio UV-Vis Spectrophotometer.  For dsRNA or cy3-dsRNA conjugation, 
solutions of PLR-Cit-Au were prepared in DI at 5:1 particle:dsRNA mass ratios.  Under 
vortexing, dsRNA was added to the particle solutions, and then allowed to mix on an end 
to end rotator for 1 hr, and then used without further purification.  For the PLR-Cit-Au 
nanoparticles, we used dsRNA labeled with cy3 to avoid complications since the Au 
nanoparticles strongly absorb at the fluorescence wavelength of Alexa Flour-488.   
 Aluminum-Magnesium layered double hydroxide nanoparticles were synthesized 
according to the method of Xu262, with modifications as prescribed by Dong263.  In brief, 
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3 mM MgCl2 and 1 mM AlCl3 were added to an excess of 0.15 M NaOH solution under 
vigorous stirring, and aged for 30 minutes.  The resultant mixture was then placed in a 
Teflon bomb and aged at 100°C for 16 hours.  The mixture was then purified by 
centrifugation and resuspension in DI. 
 Ge substituted Imogolite nanotubes were synthesized according to the method of 
Levard et. al.259. These nanotubes are structural analogues to imogolite (Al2SiO3(OH)4), a 
naturally occurring aluminosilicate. A mixture of monomeric Al (in the form of AlClO4) 
and Ge (in the form of Ge(EtO)4) with [Al]/[Ge] ratio of 2 was hydrolyzed to a hydrolysis 
ratio ([OH]/[Al]) of 2. This mixture was heated at 95°C during 5 days and then dialyzed 
using a 8000 Da membrane against ultrapure water to remove residual salts and excess 
alcohol. Hereafter, the obtained aluminogermanate are referred toas imogolite.  The tubes 
were functionalized with dsRNA or Alexa Fluor 488-dsRNA in water at a 10:1 
imogolite:dsRNA mass ratio, as described above. 
 Hydrodynamic diameter of each material was determined by dynamic light 
scattering using a Malvern Zetasizer Nano ZS, at 25°C in water, using polystyrene 
cuvettes for DLS (Malvern Panalytical DTS0012, Westborough, MA, USA).  Zeta 
potential of each material was determined by phase analysis light scattering using the 
same instrument, in folded capillary cells (Malvern Panalytical DTS1070, Westborough, 
MA, USA) at 25°C in water.  The Hückel approximation was used for calculation of all 
reported zeta potentials. 
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4.3.6 C. elegans Exposures 
 Nematodes were age synchronized according to established protocols and allowed 
to hatch on 10 cm K-agar plates seeded with E. coli strain OP50180.  After 24 hours, 
L1/L2 nematodes were rinsed from K-agar plates with K-medium (51.3 mM NaCl, 31.6 
mM KCl) and placed in 15 mL polypropylene centrifuge tubes.  Tubes were then 
centrifuged at 130 x g, and the supernatant was drawn off, leaving a compact worm 
pellet.  C. elegans dsRNA and nanomaterial/dsRNA conjugate exposures were conducted 
in 0.2 mL PCR tubes.  In each tube, 2 μL compact worm pellet was combined with 8 μL 
K-medium, followed by 10 μL dsRNA or nanomaterial/dsRNA in water to the final 
indicated concentration of dsRNA, giving a final K-medium concentration of 50% (25.65 
mM NaCl, 15.8 mM KCl).  Controls were produced as above, with DI used in place of 
dsRNA.  For the Alexa Fluor 488 and cy3 labeled exposures, a fixed concentration of 100 
ng/μL dsRNA was used in each exposure group.  PCR tubes with exposure medium and 
nematodes were incubated overnight at 20°C. 
4.3.7  Imaging and Image Processing 
 All C. elegans imaging was performed using a Nikon Eclipse 90i microscope 
equipped with Nikon Intensilight C-HGFI Epifluorescence Illuminator, Nikon FITC, 
TRITC, and Texas Red filter cubes, and a Nikon DS-Qi1Mc camera (Tokyo, Japan).  The 
objective used for all images was a Nikon Plan Apo 20X/0.75 DIC N2 WD 1.0.  For each 
exposure group, an 8 μL drop of exposure media and nematodes was placed on a glass 
microscope slide, followed by a 2 μL drop of levamisole.  A cover slip was then used to 
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secure the nematodes and media.  Each captured image consisted of a DIC image and a 
fluorescent channel image.  All DIC images were captured with autoexposure as selected 
by the NIS-Elements software.  For the GFP and Alexa Fluor 488 channel images, the 
exposure time was 5 seconds, using the FITC filter cube.  For the mCherry channel 
images, exposure time was 2.5 seconds using the Texas Red filter cube.  For the cy3 
channel images, exposure time was 5 seconds using the TRITC filter cube. 
 Image analysis was performed using Fiji185.  For quantification of GFP and 
mCherry fluorescence intensity, the background was first subtracted from the fluorescent 
channel using the rolling ball method provided with Fiji, using a rolling ball radius of 50 
pixels.  Regions of interest (ROI) were drawn around nematodes in each image using the 
DIC channel.  Mean pixel intensity was then measured in each ROI.  For each exposure 
replicate, five nematodes were measured in this way, and the mean these measurements 
was used as the group mean pixel intensity.  Each treatment consisted of three separate 
exposure replicates, for fifteen total observed nematodes per treatment. 
4.3.8  Statistical Analysis 
 All statistical analyses were performed using SAS 9.4.  Comparisons between 
groups in the knockdown experiments were conducted using PROC GLM, with multiple 
comparison corrections performed by Dunnett’s one-tail test. 
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4.4 Results 
4.4.1  Particle Characterization 
Material Hydrodynamic 
Diameter (- dsRNA) 
(nm) 
Hydrodynamic 
Diameter 
(+dsRNA) (nm) 
Zeta Potential  
(-dsRNA) (mV) 
Zeta 
Potential 
(+dsRNA) 
(mV) 
Poly-L-
Arginine-
Citrate-Au 
43.2 (7.8) 59.7 (7.8) 86.9 (0.8) 45.9 (2.1) 
Poly-L-Lysine N/A 351.5 (32.8) N/A 35.3 (4.8) 
Poly-L-Arginine N/A 163.8 (7.0) N/A 77.5 (3.6) 
Layered 
Double 
Hydroxide 
198.2 (76.8) 296.8 (102.9) 36.7 (0.4) -32.9 (4.7) 
Ge-Doped 
Imogolite 
467.4 (26.9) 313.2 (22.4) 70.9 (6.7) -54.1 (2.9) 
 Table 4.1 – Intensity weighted hydrodynamic diameter and apparent zeta potential 
of the materials used in this study before and after complexation with dsRNA.  Data 
shown is mean and (standard deviation) (n=3). 
 The PLR-Cit-Au particles and LDH particles both exhibited a slight increase in 
hydrodynamic diameter following the addition of dsRNA (Table 4.1), as would be 
expected with an additional polymer layer on the surface of these materials.  
Hydrodynamic diameter of PLR and PLK alone were not determined, as these polyplexes 
exist only upon addition of dsRNA.  PLR polyplexes were smaller than PLK polyplexes, 
likely due to the higher charge of PLR, resulting in improved stability and tighter binding 
of dsRNA.  Likewise, DLS measurements of the imogolites were complicated by the 
assumption of spherical shape necessary for DLS approximations.  Since imogolite 
nanoparticles are high aspect ratio cylinders, interpretation of DLS measurements of 
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these materials represents a spherical equivalent diameter.  All of the tested materials 
initially exhibit a high positive zeta potential, as measured by PALS (Table 4.1).  The 
PLR-Cit-Au nanoparticles, PLK, and PLR polyplexes retain their positive charge upon 
addition of dsRNA.  Upon addition of dsRNA, the LDH and Imogolites exhibit a charge 
reversal.  This phenomenon was observed at even at low (1:1) mass ratios of 
nanomaterial:dsRNA (Table 4.1). 
 
Figure 4.1 – Transmission electron micrographs of the nanomaterials studied in this 
work.  Note differences in scale bars.  A – Poly-L-Arginine Citrate Gold; B – Poly-L-
Arginine; C – Poly-L-Lysine; D – Magnesium-Aluminum Layered Double Hydroxide; E 
– Germanium Doped Imogolite 
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Figure 4.2 – Binding assays for poly-L-arginine citrate gold nanoparticles, magnesium-
aluminum layered double hydroxide nanoparticles, poly-L-lysine polyplex, and poly-L-
arginine polyplex.  Percent bound dsRNA was determined by quantitation of dsRNA 
remaining in supernatant following centrifugation of each polyplex or nanomaterial.     
 Transmission electron micrographs of the PLR-Cit-Au particles show a spherical 
morphology (Fig. 4.1A), similar to that found in other literature, with no deviation from 
the manufacturer’s description.  TEM images of the polyplexes (Fig 4.1B, 4.1C) reveal a 
generally spheroid morphology, but with a somewhat amorphous appearance, as would 
be expected from self-assembled polymer materials.  The LDH particles have a plate-like, 
hexagonal appearance (Fig. 4.1D), similar to those described in other studies.  The Ge-
imogolites were difficult to image due to low electronic contrast, and beam damage 
incurred during imaging, but generally adhere to the expected size and morphology 
parameters from other studies. 
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 From our binding and gel electrophoresis assays (Fig. 4.2), we were able to 
determine appropriate mass ratios for each nanomaterial:dsRNA.  In general, we sought 
to achieve as close to 100% dsRNA binding as possible, while limiting the amount of 
excess nanomaterial present to prevent complications due to exposure to these materials 
during the in-vivo assays. 
4.4.2  Knockdown in C. elegans 
 
 Figure 4.3 – Gene knockdown in transgenic C. elegans reporter strains using solid 
nanoparticles.  Bars represent percent of control fluorescence in treated groups. 
Asterisks represent difference from control as determined by ANOVA with Dunnet’s one 
tail correction (NS = p>0.1; * = p<0.1; ** = p<0.05; *** = p<0.01; n = 3).  A – 
Knockdown in EG7987 (mCherry) using dsRNA and poly-L-arginine-citrate-
gold/dsRNA nanoparticles.  B – Knockdown in CGC4 (GFP) using dsRNA and Ge-
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Imogolite/dsRNA nanotubes.  C – Knockdown in CGC4 (GFP) using dsRNA and layered 
double hydroxide nanoparticles. 
 
 Figure 4.4 – Gene knockdown in transgenic C. elegans reporter strain CGC4 
using polyamino acids.  Bars represent percent of control fluorescence in treated groups.  
Asterisks represent difference from control as determined by ANOVA with Dunnet’s one 
tail correction (NS = p>0.1; * = p<0.1; ** = p<0.05; *** = p<0.01; n = 3).  A – 
Knockdown in CGC4 (GFP) using dsRNA and poly-L-lysine/dsRNA. B – Knockdown in 
CGC4 (GFP) using dsRNA and poly-L-arginine/dsRNA. 
 In the PLR-Cit-Au system, we found it necessary to target mCherry in the 
transgenic C. elegans strain EG7987, due to the spectral overlap of the absorption 
wavelength of 20 nm gold nanoparticles (~525 nm)264 and the emission wavelength of 
GFP (~509 nm)265.  We were able to successfully target mCherry using a synthetic, in-
vitro synthesized dsRNA, and the exposure concentrations necessary for a detectable 
phenotype were similar to those needed for knockdown of GFP (Fig. 4.3A, 4.3B).  When 
using the PLR-Cit-Au/dsRNA nanoparticles, a slight decrease in fluorescence was 
observed in the 20 ng/μL exposure groups, but this result was not statistically significant 
at the α<0.1 level (Fig 4.3A).   
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 Similarly, we were able to successfully target GFP using synthetic dsRNA 
constructs (Fig 4.3B).  However, Ge-Imogolite/dsRNA composites failed to knock down 
GFP at 100 ng/μL dsRNA, the lowest concentration at which fluorescence reductions 
were observed for naked dsRNA (Fig 4.3B).  By contrast, LDH/dsRNA constructs were 
highly effective at GFP knockdown, at concentrations lower than necessary for 
knockdown with naked dsRNA (Fig 4.3C), though knockdown did not decrease as a 
function of increasing concentration of dsRNA. 
 PLK and PLR polyplexes both failed to knock down GFP to any appreciable 
degree (Fig 4.4A, 4.4B).  In many of the treatment groups, particularly within the PLK 
groups, an increase in fluorescence is observed. 
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4.4.3  Uptake and Distribution of Nanomaterial/Fluorescent-dsRNA Composites 
 
 Figure 4.5 – Images of Caenorhabditis elegans exposed to various nanomaterials 
and dsRNA labeled with fluorescent tags.  In each exposure, wildtype C. elegans were 
exposed to 100 ng/μL dsRNA with the indicated nanomaterial.  Insets are DIC images of 
the corresponding fluorescent channel.  A – Alexa Fluor 488-dsRNA alone.  B – Poly-L-
lysine/Alexa Fluor 488-dsRNA.  C – Poly-L-arginine/Alexa Fluor 488-dsRNA.  D – 
Layered Double Hydroxide/Alexa Fluor 488-dsRNA.  E – Ge-Imogolite/Alexa Fluor 
488-dsRNA.  F – Poly-L-arginine-citrate-gold/Cy3-dsRNA.  Cy3 was used as the 
fluorescent tag in this assay due to the spectral overlap of gold nanoparticles and Alexa 
Fluor 488. 
 In a soaking assay containing only dsRNA labeled with Alexa Fluor 488, dsRNA 
is readily ingested by C. elegans, and fully coats the intestine (Fig. 4.5A).  A small 
amount of dsRNA is present in the pharynx, but the majority is concentrated past the 
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terminal bulb.  The distribution of dsRNA is uniform within the intestine and in the 
exposure medium, with few aggregates, implying that the dsRNA remains fully in 
solution under this exposure scenario.  In a soaking assay using PLK polyplexes, dsRNA 
is prominently concentrated in the pharynx, with some evidence of passage into the 
intestine, though overall concentrations of dsRNA within the organism are far lower than 
with naked dsRNA (Fig. 4.5B).  Some aggregates are apparent in solution as well, 
evidence of the successful formation of polyplexes.  In exposures to PLR polyplexes, no 
labeled dsRNA passes beyond the buccal cavity, and prominent aggregates are present 
around the cuticle of the lips (Fig. 4.5C).  LDH/dsRNA composites behave in a manner 
similar to naked dsRNA (Fig. 4.5D).  There are large concentrations of dsRNA present 
throughout the intestine, small amounts visible in the pharynx, and large aggregates in the 
exposure medium.  Ge-Imogolite/dsRNA composites accumulate in the pharynx, similar 
to the PLK polyplexes (Fig. 4.5E).  Some of the labeled dsRNA appears to enter the 
intestine, but the majority is localized above the terminal bulb.  Overall, far less dsRNA 
is internalized than in either the LDH or naked dsRNA groups.  Some large aggregates 
are present in solution, though many smaller particles are also apparent.  Uptake of these 
particles was similar to that of naked dsRNA and the LDH/dsRNA composites (Fig. 
4.5F), with uniform distribution throughout the intestine.  
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 Figure 4.6 – DIC images of C. elegans injury associated with poly-L-
arginine/dsRNA polyplex exposure.  All exposures were conducted with a 5:1 
polymer:dsRNA ratio, and total polymer concentration is displayed below each image.  
Extent of lesion appears to increase with increasing exposure concentration. 
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 Figure 4.7 – DIC images of C. elegans exposed to poly-L-lysine/dsRNA and 
poly-L-arginine/dsRNA polyplexes. 
Zoomed insets provided to illustrate a normal pharynx (poly-L-lysine) and abnormal 
(poly-L-arginine).  The lesion is apparent at the pharynx of the poly-L-arginine exposed 
nematodes. 
 An interesting phenomenon was apparent in the PLR exposure groups.  In each, 
there is evidence of a lesion around the mouthparts of C. elegans.  The size and severity 
of this lesion is concentration-dependent by PLR concentration (Fig. 4.6).  Where 
present, this lesion shows as a withered appearance of the cells surrounding the buccal 
cavity, and, in the case of high concentrations, into the pharynx itself (Fig. 4.6).  The 
localization of the lesions correlates strongly with the presence of aggregates as seen in 
the Alexa Fluor 488-dsRNA images (Fig. 4.5C, 4.7).  We did not observe similar lesions 
in the PLK (Fig. 4.7), naked dsRNA, or control groups. 
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4.5 Discussion 
  The primary aim of this work was to identify nanomaterials or polymers which 
improve some aspect of dsRNA delivery using the model nematode C. elegans.  Of the 
materials we tested (two polymers, two inorganic solids, one polymer-coated Au-core) 
only Mg-Al LDH nanoparticles offered gene knockdown even comparable to naked 
dsRNA (Fig. 4.3C). 
The lack of efficacy of the polymer composites is unsurprising, given the poor 
(PLK) or absent (PLR) uptake of labeled dsRNA using these systems (Fig. 4.5B, 4.5C).  
Curiously, the uptake characteristics of PLR-Cit-Au/dsRNA appear similar to naked 
dsRNA and LDH/dsRNA (Fig. 4.5F, 4.5A, 4.5D), in spite of insignificant knockdown 
compared to either.  However, significant aggregates of PLR-Cit-Au/dsRNA were 
present following the 24 hour incubation period with the C. elegans.  Recent work has 
demonstrated that the use of positively charged nanoparticles in C. elegans assays can 
give rise to significant artifacts due to agglomeration of the positively charged particles 
with practically everything else in the exposure medium266.  It is highly possible that a 
similar phenomenon would cause this system to fail in any knockdown attempts.  Further, 
it is equally possible that following the initial ingestion of stable particles early in the 
exposure, the particles adhere strongly to the lining of the intestine but are not further 
assimilated by cells.  This would give rise to the appearance of Figure 4.5F, where 
labeled dsRNA is clearly present in the gut, but does not appear to have translocated any 
further after 24 hours.  Though the Ge-imogolite/dsRNA particles are consumed by the 
nematodes, there is far less total dsRNA present than either the naked dsRNA or LDH 
systems.  This likely accounts for the failure of this material to cause any observed 
knockdown.  Another curiosity is the success of the LDH nanoparticles in spite of the 
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negative charge they possess following the addition of dsRNA.  Conventional wisdom in 
the field of nucleic acid delivery is that positive charge is seemingly mandatory for 
successful transfection.  However, some studies have found that in certain, specific 
conditions, particles with a strong negative zeta potential can successfully deliver siRNA 
and knock-down genes267.  Further, there is some evidence that materials which are 
capable of charge-reversal exhibit enhanced gene delivery, likely due to enhanced 
lysosomal escape268, 269, 270.  Given the relatively small amount of dsRNA required to 
cause a charge reversal for LDH nanoparticles, there is a good possibility that these 
materials can switch between charge signs rather easily without aggregation, and could 
possibly do so in strongly acidic cellular compartments such as the lysosome.  Such 
properties would aid in endosomal escape and would account for the effectiveness and 
potency of LDH nanoparticles for gene silencing271. 
 The buccal lesion associated with PLR exposure (Fig. 4.6, 4.7) is concerning, and 
has, to our knowledge, been previously unreported.  Interestingly, some recent work has 
been conducted in human cell lines that utilizes poly-L-arginine as a mimic for the 
cationic major basic protein (MBP)272.  The authors found that apoptosis is initiated in 
cells exposed to poly-L-arginine in a concentration-dependent fashion.  Similarly, we 
observed a concentration dependence on the extent of injury related to PLR exposure in 
C. elegans.  This is also likely the reason that no injury is observed in the PLR-Cit-Au 
particle exposures, since the total mass of PLR would be markedly lower in these 
treatments.  This injury, combined with the lack of efficacy of PLR polyplexes for gene 
knockdown, places extreme doubt upon the usefulness of PLR for use with agricultural 
RNAi.  
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4.6 Conclusions 
 Future work into substrates for dsRNA delivery in an agricultural context would 
do well to explore several directions as indicated in this work.  First, though we explored 
two polyamino acids, and both quite readily failed, others, such as poly-L-histidine, may 
prove effective273.  It is worth noting that poly-L-histidine has a side chain pKa of 
~6.5274, more similar to that of chitosan than the other polyamino acids, and chitosan has 
been shown to be a highly effective dsRNA delivery agent.  In addition, though 
polyamino acids are generally regarded as less toxic than other synthetic polycations, we 
discovered significant deleterious effects associated with the use of PLR.  Our earlier 
work similarly discovered unreported effects associated with chitosan.  These 
observations again highlight the extreme care that must be taken when assessing the 
toxicity of nanomaterials, particularly in those which are often assumed to be of low 
toxicity.  Next, though LDH nanoparticles proved effective in this work, numerous 
variables can be changed to possibly further enhance these particles, while still adhering 
to the general design principles we established in this work for agricultural use.  Size, 
shape, and cation ratio are all malleable142, 258 and may alter efficacy.  The addition of 
simple adjuvants such as low molecular weight PEG may also improve gene delivery and 
environmental stability100.   
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CHAPTER 5. CONCLUSIONS AND FUTURE DIRECTIONS 
 In this work, I have characterized the uptake and efficacy of several nanomaterials 
for use as delivery agents for double-stranded RNA using the model nematode 
Caenorhabditis elegans.   
 In Chapter 2, I investigated the uptake characteristics of chitosan/dsRNA polyplex 
nanoparticles (PNs).  I found that PNs are generally as effective as naked dsRNA at 
knockdown of a reporter gene in C. elegans at equivalent dsRNA concentrations.  
However, the cellular uptake mechanisms of PNs and naked dsRNA differ greatly.  Using 
mutant strains of C. elegans, I determined that PNs are capable of inducing an RNAi 
response in animals lacking the transporters normally associated with uptake of dsRNA 
from the environment.  By the use of chemical inhibitors of clathrin-mediated 
endocytosis, I was able to determine that this was the likely mechanism that assimilates 
PNs in C. elegans.  In addition to these findings, I observed a significant off-target effect 
of chitosan exposure: downregulation of a major myosin isoform. 
 In Chapter 3, I again investigated chitosan/dsRNA polyplexes, this time focusing 
upon environmental variables that could alter the efficacy of the particles.  I found that 
PN efficacy at gene knockdown in C. elegans was unaffected by inorganic phosphate or 
nitrate concentration, but inhibited at pH greater than 7, and strongly inhibited by the 
presence of natural organic matter.  As would be expected, the inorganic ions did not 
alter the hydrodynamic diameter or zeta potential of the particles to any appreciable 
degree, whereas increases in pH caused a decrease in the zeta potential of the particles, 
and natural organic matter aggressively aggregated the particles, and shifted the zeta 
potential from highly positive to highly negative. 
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 In Chapter 4, I explored the properties of other nanomaterials as an attempt to 
identify a means to improve RNAi response in C. elegans.  Of the tested materials, only 
layered double hydroxide nanoparticles caused any gene knockdown at all.  All others 
failed to knock down genes to any appreciable degree, with naked dsRNA being more 
effective in all of these cases.  LDH based nanomaterials are therefore due further 
attention as delivery agents for dsRNA.  In addition to this finding, I identified a 
significant injury located at the mouthparts and pharynx of poly-L-arginine exposed C. 
elegans.  We attribute this injury to artificially induced apoptosis of the cells in the 
vicinity of poly-L-arginine exposed tissues, and can thus categorically reject any future 
uses of poly-L-arginine alone. 
Future directions of this line of work have multiple avenues to pursue.  First, although I 
identified significant shortcomings associated with the use of chitosan, it is worth noting 
that this material has performed better than most tested in Chapter 4, and fulfills the 
enormous practical hurdle for agricultural use in that it is inexpensive and abundant.  
Investigations into minor modifications of chitosan are worth pursuing.  For instance, 
trimethyl chitosan is more soluble in water that native chitosan, and could thus perform 
better in high pH environments, an issue specifically identified in Chapter 2.   
 Though I studied a number of different classes of nanomaterial for dsRNA 
delivery, one major class that I was unable to pursue was that of nanocapsules, derived, 
for instance, from PGLA.  When introduced into the environment, it will be nearly 
impossible to protect these materials from interaction with naturally occurring ligands.  
To protect the positively charged components of dsRNA delivery systems from 
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interactions with these ubiquitously occurring (and almost universally anionic) substrates, 
nano- or micro-encapsulation should be explored. 
 Another area of study that I was unable to pursue in this work is the practical 
consideration of dsRNA storage.  As has been thoroughly established above, dsRNA is 
extraordinarily labile, and susceptible to rapid degradation.  Even if a given nanomaterial 
does not impart improved uptake or efficacy as a crop protection agent, there may yet be 
benefits to its use as a preservative.  Studies investigating the ability of nanomaterials to 
improve adverse storage conditions should consider variables such as temperature, 
moisture content of dried products, bacterial contamination, and time. 
 Lastly, I would strongly encourage future work to adhere to the general research 
principles I have endorsed herein.  That is, when studying nanomaterials for use in 
agricultural settings, consider realistic exposure scenarios using whole organisms as 
model systems, and avoiding doses and concentrations that exceed those likely to be 
feasible at field-scale. 
 The entirety of this work is predicated on the vast potential of RNAi as a 
biological control agent.  The broader environmental movement exists principally 
because scientists were able to recognize the deleterious effects of unchecked pesticide 
use.  At the same time, an increasing global population has driven demand for food and 
other agricultural products ever higher.  In order to address both of these concerns, the 
greater scientific community has continually been searching for technologies that are 
both safe and effective for control of insect pests.  RNAi is the only known pesticide that, 
when properly designed and utilized, is absent all the harmful implications of small 
molecule pesticides, both persistence and toxicity.  Development of effective RNAi based 
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biological control agents in many ways represents the realization of Carson’s ‘ideal’ 
pesticide – less a ‘biocide’ than any to come before it.  My overarching goal in this work 
has been to advance our understanding of how RNAi can be improved to the point of 
practical use.  To this end, I have focused upon exogenous dsRNA and associated 
nanocarriers, as this delivery paradigm offers considerably more flexibility than crop 
transgenesis.  Prior to this project, little work had been conducted which investigated the 
interplay between dsRNA functionalized nanomaterials and environmental variables.  A 
thorough understanding of these processes will be necessary to successfully implement 
RNAi-based insect control methods.  My work here is a starting point from which future 
scientists can investigate these interactions, and develop materials that are equally 
effective under any environmental conditions.  Equally important is an understanding of 
the interactions between biota and dsRNA-conjugated nanomaterials.  My work is the 
first to demonstrate specifically that dsRNA-conjugated nanomaterials are assimilated 
into cells in ways that are more similar to other nanomaterials than naked dsRNA.  This 
distinction will have lasting implications for both the development of RNAi biological 
control agents, as well as safety assessments therein.  Lastly, it is important to note that 
this project was able to identify off-target effects associated with multiple nanocarriers 
typically regarded as safe and non-toxic.  As noted earlier, a critical distinction must be 
drawn between the safety of a given dsRNA transcript delivered alone, and one delivered 
with nano-scale adjuvants.  In-silico methods for predicting dsRNA toxicity, in the form 
of sequence homology, for instance, would fail to recognize the effects induced by the 
carrier in cases such as those found here.  Further, the assumption of an absence of acute 
toxic effects as extrapolated from prior work must always be subject to rigorous scrutiny.  
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Though lesions such as seen with our poly-L-arginine experiments may have become 
apparent in cell culture studies, it is far less likely that the effects seen with our chitosan 
experiments would have been as apparent, as the affected and observed endpoints occur 
at the organismal rather than cellular level.  Diligence in assessment of RNAi based 
biological control agents must be undertaken at all levels of development to ensure that 
we, as a community, can see the potential in these materials brought to fruition. 
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